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1. INTRODUCTION 
 
Frozen shoulder syndrome (FSS), also known as “adhesive capsulitis”, 
“scapulohumeral periarthritis”, “stiff and painful shoulder”, “periarticular 
adhesion”, “adherent subacromial bursitis”, “hypomobile syndrome” involves 
the shoulder joint and surrounding tissues (Neviaser, 1945; Neviaser and Han-
nafin, 2010; Cinar et al., 2010; Manske and Prohaska, 2010; Lorbach et al., 
2010; Hsu et al., 2011). FSS occurs in 2-5% of the adult population (Leung and 
Cheing, 2008; Lorbach et al., 2010; Cinar et al., 2010; Favejee et al., 2011), and 
in up to 20% of patients with diabetes (Mavrikakis et al., 1989; Balci et al., 
1999). However, 70% of patients are women (Sheridan and Hannafin, 2006), 
and there has been a secular trend of increasing among women more recently 
(White et al., 2011). FSS usually presents in the sixth decade of life (Dias et al., 
2005; Jewell et al., 2009; Gaspar and Willis, 2009), and onset before the age of 
40 is very uncommon (Dias et al., 2005).  
 FSS may develop after concurrence with shoulder trauma, cardiovascular 
and chronic lung diseases, pulmonary tuberculosis, diabetes, stroke or tumour, 
thyroid disease (Milgrom et al., 2008), prolonged immobilization, and when it 
concurs with an autoimmune disease in the patient (Hannafin and Chiaia, 2000; 
Garsland et al., 2000; De Ponti et al., 2006). FSS commonly begins gradually 
(61%) but in many cases FSS develops rapidly over a 24-48 hour period (39%). 
The condition has not been reported to have a disposition for race (Hsu et al., 
2011) and recurrence of the FSS is rare (Cameron et al., 2000). 
 FSS is a disease with unclear etiology whereas it is a long-lasting disease 
and needs patience from the patients as well as doctors and physiotherapists.  
The FSS patients had shoulder pain and localized discomfort near the insertion 
of the deltoid muscle, limitation and pain during shoulder active (aROM) and 
passive range of motion (pROM), especially during flexion (FL), external (EXR) 
and internal rotation (INR) and with diminishing shoulder function (Neviaser 
and Neviaser, 1987). Patients with FSS have difficulties in everyday activities 
(dressing, grooming, and performing overhead reaching activities and so on for 
a period of several months to several years) and shoulder pain disturbing sleep 
at night on the affected side, which is a key diagnostic sign (Bunker and 
Anthony, 1995; Watson et al., 2000; Boyles et al., 2005; Jewell, 2009; 
Blanchard et al., 2010), waking up at night secondary to shoulder pain (Miller et 
al., 1996) and muscle spasms are common in patients with FSS (Wadsworth 
1986).  
 The characteristic “shrug sign” develops in patients with FSS during 
glenohumeral joint elevation, where the scapula migrates upward prior to 60 
deg of abduction (ABD). This indicates compensation due to the lack of 
capsular flexibility as well as a change in the central nervous system’s motor 
pattern due to inadequate movement in the involved shoulder joint. Adaptive 
posture may develop in patients with FSS, such as anterior shoulders or 
increased thoracic kyphosis (Page and Labbe, 2010).  
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Usually in the studies in patients with FSS, shoulder joint recovery is assessed 
by shoulder aROM or pROM, pain and different shoulder and health question-
naires. In our study, we also paid attention to the recovery of shoulder region 
muscle isometric strength, isometric working capacity, fatigability and 
endurance.  
 The main goal of this study was to follow shoulder aROM, shoulder pain 
and shoulder muscle function recovery in patients with FSS, who were treated 
conservatively or with manipulation under general anaesthesia (MUA) and 
compare the involved extremity with the uninvolved extremity.  
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2. REVIEW OF LITERATURE 
 
2.1. Definition and classification  
of frozen shoulder syndrome 
The definition for adhesive capsulitis, which was published by the association 
of American Shoulder and Elbow Surgeons is: “a condition of uncertain etio-
logy characterized by significant restriction of both active and passive shoulder 
motion that occurs in the absence of a known intrinsic shoulder disorder” 
(Zuckerman et al., 1994). 
Zuckerman et al. (2011) recommended a completed frozen shoulder synd-
rome (FSS) definition: “Frozen shoulder syndrome is a condition characterized 
by functional restriction of both active and passive shoulder motion for which 
radiographs of the glenohumeral joint are essentially unremarkable except for 
the possible presence of osteopenia or calcific tendonitis”.  
Thus, the proposed classification model of FSS (Zuckerman et al., 2011): 
A. Primary: a diagnosis for all cases for which an underlying etiology or 
associated condition cannot be identified. 
B. Secondary: includes all cases of FSS in which an underlying etiology or 
associated condition can be identified. 
1. Intrinsic: limitation during shoulder aROM and pROM that occurs in 
association with rotator cuff disorders, biceps tendonitis, or calcific 
tendonitis, acromioclavicular arthritis.  
2. Extrinsic: an association with an identifiable abnormality remote to the 
shoulder itself (shoulder aROM and pROM found in association with 
previous ipsilateral breast surgery, cervical radiculopathy, chest tumour, 
previous cerebrovascular accident, or previous humeral shaft fracture, 
scapulothoracic abnormalities, acromioclavicular arthritis, or clavicle 
fracture, cardiopulmonary disease, Parkinson’s disease). 
3. Systemic: systemic disorders include but are not limited to diabetes, 
hyperthyroidism, hypothyroidism, hypoadrenalism, or any other condi-
tion that has been documented to have an association with the develop-
ment of FSS. 
Kelley et al. (2009) proposed the classification system, which is based on the 
FSS patients’ irritability level (low, moderate and high). In this classification 
system, irritability is determined based on shoulder pain, range of motion 
(ROM), and extent of disability. Patients with low irritability have little or no 
shoulder pain; therefore aROM and pROM are equal and disability is lower. 
These patients typically report stiffness rather than shoulder pain as the chief 
complaint. Patients with high irritability have significant shoulder pain resulting 
in the limited pROM (due to muscle guarding) and greater disability. These 
patients typically report shoulder pain rather than stiffness as the chief 
complaint (Kelley et al., 2009). 
 In conclusion, the doctors must take into account patients’ symptoms and 
problems before they diagnose FSS.  
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2.2. Frozen shoulder syndrome stages 
Using arthroscopic criteria, Neviaser and Neviaser (1987) modified four stages 
of FSS. Hannafin and Chiaia (2000), Sheridan and Hannafin (2006), Neviaser 
and Hannafin (2010) FSS stages criteria are presented in Table 1. 
 In conclusion, in the different stages patients with FSS had different prob-
lems and symptoms in the shoulder joint and surrounding tissues and felt dis-
comfort for a long period (Wolf and Green, 2002). However, the diagnosis and 
treatment depend on the patient’s complaints and medical assessment findings. 
 
 
2.3. Etiology and pathology  
of frozen shoulder syndrome 
The etiology of FSS is still unknown. Cases may be related to immunologic, 
biochemical, or hormonal reasons. Wolf and Green (2002) concluded that the 
idiopathic FSS is an exhausting condition. DePalma (1963) wrote that aging is 
an important etiological factor of FSS. With aging, changes take place in the 
shoulder joint’s connective tissue elements of the musculotendinous cuff, which 
cause it to lose its elasticity and undergo regressive changes.  
 Studies indicate that in patients with FSS, inflammational factor immuno-
globulin A was decreased and remained so after clinical recovery (Bulgen et al., 
1978; Bulgen et al., 1984). However, it has been found in studyes that several 
cytokines: interleukin 1β, tumour necrosis factor-alpha (Ko and Wang, 2011), 
interleukin 6, interleukin 8 were elevated in patients with FSS (Kabbabe et al., 
2010). The levels of the fibrinogenic cytokine matrix metalloproteinase 3 
(Hutchinson et al., 1998), disintegrin and metalloproteinase with thrombospon-
din motifs 4 were elevated in patients with FSS too (Kabbabe et al., 2010). In 
this patient group, there has been an increased level of growth factors such as 
transforming growth factor beta, platelet-derived growth factor, and fibroblast 
growth factor (Bunker et al., 2000; Mullett et al., 2007) which lead to the 
development of capsular fibrosis (Ozaki et al., 1989; Border and Noble, 1994; 
Rodeo et al., 1997; Mullett et al., 2007) and the clinical symptoms of FSS (Ro-
deo et al., 1997; Mullett et al., 2007). The imbalance between aggressive 
healing, scarring, contracture and a failure to remodel may lead to protracted 
stiffening of the capsule (Bunker et al., 2000). Bunker and Anthony (1995) 
described that the pathological process was active in the fibroblastic proli-
feration and the result of this process was that the fibroblasts lay down collagen, 
which appears as a thick nodular band or fleshy mass.  
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In the immunological pathogenesis of this condition, reduction in the lympho-
cyte transformation to phytohaemagglutinin was found (Bulgen et al., 1978). On 
the other hand, C-reactive protein and concanavalin increased (Bulgen et al., 
1982; Bulgen et al., 1984). Hand et al. (2007) discovered immunocyto-chemical 
evidence of both chronic inflammation and proliferative fibrosis. High 
vascularity (Nago et al., 2010) and nerve tissue, the inflammation and fibrosis 
(Nago et al., 2010) explain why FSS is such a painful and stiff condition. The 
presence of T and B cells suggest that the pathology may be immunomodulated. 
Mast cells may be the cellular mediator between chronic inflammation and 
fibrosis (Hand et al., 2007). Harzy et al. (2004) suggest there could be an 
immunological or genetic basis for primary hypoparathyroidism and FSS. Alter-
natively, FSS may be manifestation of hypoparathyroidism. The most well-
known strong association is between diabetes and FSS (Smith et al., 2003). 
Bridgman (1972) found that in 800 diabetic patients, 86 had FSS (32 male with 
mean age of 58.3 yrs, 54 female with mean age of 59.8 yrs), however, in 600 
nondiabetic group 14 have had FSS (10 male with mean age of 57.8 yrs and 4 
female with mean age of 62.7 yrs). Moren-Hybbinette et al. (1987) found that in 
90% of diabetic patients with painful and restricted shoulder mobility are 
affected in the activities of daily living (ADL) in the acute phase, whereas 17% 
of patients had restricted mobility at the end of the study.  
 Patten and Hillel (1993) proposed that FSS is a principial component of the 
cranial nerve XI syndrome that can significantly compound the morbidity of a 
neck dissection even when the accessory nerve recovers. Cakir et al. (2003) 
found in their study that the prevalence of FSS was highest in patients with 
subclinical thyrotoxicosis (17%).  
 Intraoperative findings in patients with FSS are extensive scarring of the in-
ferior glenohumeral ligament, axillary recess, degenerative tearing of the su-
perior labrum, where areas of the biceps and rotator cuff appear intact (Roubal 
and Placzek, 2008).  
 The histology showed fibrosis, hyalinization, and fibrinoid degeneration in 
the contracted connective tissues, fibrosis of the subsynovial tissue and an 
absence of the synovial cell layer on the joint side of the rotator interval (Ozaki 
et al., 1989). However, synovial proliferation and hypervascular changes are 
typical of the initial phases, while fibrosis is typical in later phases of FSS 
(Neviaser, 1987; Neviaser and Neviaser, 1987; Neviaser and Hannafin, 2010).  
 It has been found in studies that in patients with FSS significant bone loss in 
the humerus of the affected extremity occurs, but in the long term, induced bone 
loss shows good recovery in patients with FSS (Leppälä et al., 1998).  
 Uhthoff and Boileau (2007) concluded that in patients with FSS, fibroplasia 
and contracture are two distinct processes. Hagiwara et al. (2012) analyzed 
changes in the capsule and found that in patients with FSS the number of cells 
was higher and capsular tissue was stiffer. They concluded that chondrogenesis 
plays a critical role in the pathogenesis of idiopathic FSS. 
 In conclusion, the etiology of FSS is multifaceted, damage has been found in 
different shoulder joint structures and different processes have taken place. This 
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may explain why FSS is long-lasting, goes through many stages and is so 
displeasing for the patients. 
 
 
2.4. Assessment of patients with  
frozen shoulder syndrome 
The doctors and physiotherapists have a lot of different methods for assessing 
the patients with FSS before, during and after therapy. FSS diagnosis is based 
on medical history, physical examination and clinical symptoms presentation. 
The examination of the patients with FSS includes observation, cervical exami-
nation, assessment of shoulder joint ROM, assessment of the shoulder region 
muscle strength and provocative testing (Pearsall and Speer, 1998). After that, 
the diagnosis FSS is commonly given when other causes can be excluded, such 
as major trauma, rotator cuff contusion, labral tear, bone contusion, subacromial 
bursitis, cervical or peripheral neuropathy, or history of a previous surgical 
procedure that may have led to shoulder stiffness. If there is no indication of the 
above pathologies and radiographs do not demonstrate osteoarthritis, the 
diagnosis of FSS can be given (Manske and Prohaska, 2010; Ahn et al., 2011). 
Binder et al. (1984) found on plain x-rays that in patients with FSS in the 
involved shoulder, the shoulder was normal in 30 of the 42 patients. Changes in 
the shoulder joint in patients with FSS were: decreased distance between the 
acromion and the humeral head, degenerative changes in the humeral head 
which involved greater tuberosity.  
 
 
2.4.1. Arthrography and magnetic resonance imaging 
In patients with FSS, the arthrography shows a decrease in the joint capacity 
with obliteration of the reflected axillary fold, the subscapularis bursa is 
decreased in size or not visualized at all and, the bicipital sheath is well outlined 
(Neviaser, 1962; Siegel et al., 1999; Yilmaz et al., 2007). Binder et al. (1984) 
divided patients with FSS into three subgroups: (1) normal group – shoulder 
joint volume at least 15 ml, (2) capsulitis group – marked reduction in joint 
volume, loss of distensibility of the shoulder joint, marked irregularity of joint 
outline and early lymphatic filling, (3) rupture group – rupture of the rotator 
cuff.  
 Magnetic resonance (MR) arthrographic findings in patients with FSS in-
cluded the thickening of the coracohumeral ligament (correlates with ROM 
limitations in INR and EXR (Lee et al., 2012) and thickening the joint capsule 
in the rotator cuff interval, and subcoracoid triangle sign (Ozaki et al., 1989, 
Lee et al., 2003; Mengiardi et al., 2004; Song et al., 2011; Li et al., 2011; 
Teixeira et al., 2012). In the magnetic resonance imaging (MRI), Ahn et al. 
(2012) found that the thickening and gadolinium improvement of the shoulder 
joint capsule in the axillary recess are associated with shoulder ROM limitation 
and shoulder pain in patients with FSS. It has been found in studies that rotator 
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interval dimensions in shoulders with FSS were significantly different com-
pared with normal controls (Kim et al., 2009). It was concluded that the absence 
of a full-thickness rotator cuff tear, the thickness of a capsule and synovium 
greater than 3 mm at the level of the axillary recess is a practical MR criterion 
for diagnosing FSS on oblique coronal T2-weighted MR arthrography images 
without fat suppression (Jung et al., 2006). Sofka et al. (2008) evaluated 
noncontrast MRI findings in patients with FSS and correlated them with clinical 
stages. They concluded that specific MRI criteria correlated with the clinical 
stage of FSS, including the thickness and signal intensity of the shoulder joint 
capsule and synovium as well as the presence and severity of scarring in the 
rotator interval. In cases of patients suspected of having FSS, contrast-enhanced 
magnetic resonance imaging should be obtained (Gokalp et al., 2011).  
 In conclusion, understanding the anatomy and pathology of the shoulder 
joint, especially of the rotator interval, may be helpful for successful diagnosis 
and treatment of patients with FSS.  
 
 
2.4.2. Active and passive range of motion 
FSS is believed to be a self-limiting condition, lasting 18–30 months period 
(Wies, 2005; Baums et al., 2007; Tasto and Elias, 2007; Brue et al., 2007). On 
the other hand, studies report that 20–50% of patients suffer a long-term motion 
deficit that can at times last up to 10 years (Binder et al., 1984; Bulgen et al., 
1984; Shaffer et al., 1992). Shaffer et al. (1992) evaluated sixty-two patients 
with FSS who had been treated nonoperatively. Subjective and objective 
follow-up lasts an average of seven years. 50% of these patients had either mild 
pain or stiffness of the shoulder, or both. 60% of patients demonstrated some 
restriction of shoulder ROM, and 11% reported mild functional limitation. 
However, Vastamäki et al. (2012) argued that 94% of patients with spontaneous 
FSS improved to normal shoulder function and ROM without treatment. 
 The shoulder aROM and pROM in patients with FSS is usually measured 
with a goniometer. The main treatment goal in patients with FSS is decreasing 
shoulder pain and increasing shoulder ROM. Different treatment modalities in 
patients with FSS are: nonoperative treatment (Lorbach et al., 2010), inter-
ventional microadhesiolysis (Ahn et al., 2008), MUA (Ng et al., 2009; Rill et al., 
2011), arthroscopic capsular release (Cinar et al., 2010). With treatment, the 
fastest shoulder ROM recovery was usually achieved during the first 8 weeks. 
However, the recovery continued until the final follow-up. It was concluded that 
in the late stage of FSS, there was little functional impairment (Binder et al., 
1984). 
 In FSS patients, using the assessment with the three-dimensional electro-
magnetic motion capture system, a significant difference was found in shoulder 
motion loss patterns between the involved and non-involved shoulder. The INR 
less than ABD less than EXR pattern was demonstrated in 56% involved 
shoulders. No pattern was presented in 67% non-involved shoulders. With the 
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arm ABD, INR was the most limited motion in 92% involved shoulders 
(Rundquist and Ludewig, 2004).  
 In conclusion, usually after treatment the patients with FSS showed improve-
ment in the involved extremity pROM and aROM. The fastest improvement 
usually happened during the first eight weeks of therapy, after which the in-
volved shoulder ROM continued to improve, but it was not so fast and 
depended on how much the patient was exercising. 
 
 
2.4.3. Isometric and isokinetic strength    
Muscle atrophy in the rotator cuff and in the deltoid, biceps brachii, and triceps 
brachii muscles may occur in patients with FSS (Wadsworth, 1986). The muscle 
strength and endurance examination in patients with FSS may provide 
additional information about the patient’s shoulder function. It has been found 
in studies that the high-speed shoulder muscle isometric strength during EXR 
and INR of the affected shoulder decreased significantly in patients with FSS 
(Lin et al., 2009). It was concluded that isokinetic dynamometry may provide 
additional information as compared with the usual outcome measures of 
shoulder pain and function level in patients with FSS (van Meetern et al., 2006). 
Liem et al. (2008) measured isometric and isokinetic shoulder muscle strength 
during INR and EXR in FSS patients who were treated by arthroscopic capsular 
release. They found that 53 months (range 12–106 months) after surgery, the 
isometric and isokinetic shoulder muscle strength in the standard ABD position 
showed no significant side-to-side difference during the INR and EXR.  
 Literature describes that the hand-held dynamometer has been the most 
reliable tool for assessing shoulder muscle strength of the rotator cuff in 
symptomatic subjects (Hayes et al., 2002; Bohannon, 2009). It was found that 
13 weeks after MUA, the patients with FSS experienced mild weakness with 
manual muscle testing in 5.3% of patients during EXR and 10.5% during INR 
(Reichmister and Friedman, 1999). In patients with FSS, increasing muscle 
activity levels of the upper and lower trapezius in different testing positions 
occurred (120 deg FL, ABD in the frontal plane, and scapular plane, 60 deg FL, 
ABD in the frontal plane, and in the scapular plane). These indicate that patients 
with FSS compensated impaired glenohumeral motion using accessory 
musculature (Lin et al., 2005).  
 In conclusion, the condition of shoulder region muscles, especially rotator 
cuff muscles, is important in patients with FSS. The assessment of shoulder 
muscle strength and activation provide additional information about the 
patient’s shoulder function before and after treatment.  
 
 
2.4.4. Shoulder pain 
The shoulder pain associated with FSS is not only related to capsular and 
ligamentous tightness, but also to fascial restrictions, muscular tightness, and 
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trigger points within the muscles (Page and Labbe, 2010). In their long-term 
outcome study (4.4 yrs), Hand et al. (2008) demonstrated that 59% of patients 
had normal or near normal shoulders and 41% reported some ongoing 
symptoms, however shoulder pain being the most common complaint. FSS 
patients with severe symptoms at condition onset had the worst long-term 
prognosis. The patients with FSS usually report shoulder pain on palpation of 
the anterior and posterior capsule and pain that is experienced during aROM of 
the arm (Marx et al., 2007), and pain in the acromioclavicular joint (Anakwenze 
et al., 2011). It is very important to assess shoulder pain in patients with FSS 
before therapy, during the therapy process and after therapy. 
 Shoulder pain is usually assessed with a 10 or 100 point visual analog scale 
(VAS). When using the 10 point VAS scale for assessing shoulder pain, the 
average score before therapy reported in the studies has been 6–8 points; 
however, after treatment shoulder pain decreased to 0.9–3 points for average 
13–16 weeks (Reichmister and Friedman, 1999; Watson et al., 2000; Griggs et 
al., 2000; Lee et al., 2009; Huang et al., 2010; De Carli et al., 2012). Gleyze et 
al. (2011) showed in their study that in patients with stiff shoulder in the con-
ventional sub-threshold rehabilitation group and capsulotomy group, the 
shoulder pain decreased progressively during the first eight weeks.  
 Carbone et al. (2010) evaluated the coracoid pain test in patients with FSS 
and concluded that the digital pressure over the coracoideus area elicits pain in 
the vast majority of patients with FSS and, it can be considered an easy reliable 
clinical test for identifying patients with or without this condition.  
 
 
2.4.5. Self-administered questionnaires  
In the literature self-administered questionnaires for assessing patients with FSS 
are widely used, which include the global assessment, shoulder pain, ADL, re-
creational activities, athletic activities, work satisfaction and areas for improve-
ment. For shoulder pathologies, more than 40 assessment tools are available 
(Fayad et al., 2005). To assess FSS patients’ recovery, researches used con-
secutive questionnaires: Shoulder Rating Questionnaire (SRQ) (L’Insalata 1997; 
Vad et al., 2003; Diwan and Murrell, 2005; Vermeulen et al., 2006; Marx et al., 
2007); Shoulder Disability Questionnaire (Ryans et al., 2005; Vermeulen et al., 
2006; Kivimäki et al., 2007); Shoulder Pain and Disability Index (Boyles et al., 
2005). Williams et al. (1995) found that Shoulder Pain and Disability Index is 
responsive to change and accurately discriminates between patients whose 
condition improves or worsenes; Oxford shoulder score (Hand et al., 2008); 
Disabilities of the Arm, Shoulder, and Hand Questionnaire (Griggs et al., 2000; 
Wolf and Green, 2002; Bron et al., 2007); General health status was measured 
by the 36-Item Short-Form Health Survey (Griggs et al., 2000; Wolf and Green, 
2002; Vermeulen et al., 2006; Baums et al., 2007; Levine et al., 2007; Jacobs et 
al., 2009); American Shoulder and Elbow Surgeons score (Omari and Bunker, 
2001; Nicholson, 2003; Farrell et al., 2005; Baums et al., 2007; Levine et al., 
2007; Leung and Cheing, 2008; Rill et al., 2011; De Carli et al., 2012); Simple 
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Shoulder Test (Wolf and Green, 2002; Nicholson, 2003; Castellarin et al., 2004; 
Farrell et al., 2005; Baums et al., 2007; Levine et al., 2007; Rill et al., 2011; De 
Carli et al., 2012); Constant score (CS) (Andresen et al., 1998; Dodenhoff et al., 
2000; Othman and Taylor, 2002; Jerosch, 2001; Massoud et al., 2002; Diercks 
and Stevens, 2004; Quraishi et al., 2007; Wang et al., 2007; Jacobs et al., 2009; 
Wang et al., 2010; Celik 2010); Japanese Orthopaedic Association assessment 
(Ide and Takagi, 2004); Constant-Murley scale (Castellarin et al., 2004; Cheing 
et al., 2008; De Carli et al., 2012). University of Los Angeles shoulder scores 
(De Carli et al., 2012).  
 Dupeyron et al. (2010) investigated the validity, reliability, and responsive-
ness to change of The Standardized Index of Shoulder Function and found that 
it is a proper assessment tool for pain, mobility, strength and function in 
shoulder disorders, easy to administer and of good metric value. However, 
Buchbinder et al. (2007) concluded that of the general questionnaires on the 
quality of life, the 36-Item Short-Form Health Survey and Assessment of 
Quality of Life is not useful for measuring in clinical trials of interventions for 
FSS.  
 In conclusion, the point score of the evaluation scales significantly improved 
after the therapy sessions in patients with FSS. However, there is a difference 
between subjective (questionnaires) and objective (measured by a physio-
therapist) assessment results of recovery. For the treatment process evaluation it 
is important to objectively and subjectively assess patients with FSS.  
 
 
2.5. Treatment of patients with  
frozen shoulder syndrome  
FSS affects the patient’s shoulder, which is treated by different medical specia-
lists including general practitioners, orthopaedic surgeons, rheumatologists, and 
physiatrists and physiotherapists (Zuckerman et al., 2011). The primary goal of 
therapeutic intervention is to restore shoulder pain-free functional ROM. The 
treatment modalities are divided into conservative, nonsurgical and surgical 
interventions (Chambler and Carr, 2003). Surgical release should only be 
considered after failed nonoperative treatment.  
 
 
2.5.1. Three-step algorithm for managing the stiff shoulder 
Three-step stiff shoulder management algorithm proposed by Gleyze et al. 
(2011) after a complete clinical and radiological work-up: 
 
‒ First step (3 months of intensive self-rehabilitation): 
Checked and supervised treatment with a physiotherapist that stimulates and 
relieves the patient and progressively introduces conventional rehabilitation 
exercises. 
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‒ Second step (3 months to 6 months): 
As progression is favourable, supervised self-rehabilitation should be continued. 
If progression is unfavourable and it is certain that the patient is doing his best, 
performing distension or locoregional anaesthesia with intensified conventional 
rehabilitation may be warranted. When progression is unfavourable and there is 
doubt as to the patient’s willingness to work, rehabilitation should continue, but 
without proposing additional intervention. 
 
‒ Third step (6 months): 
When progression is favourable, the shoulder is considered to be normal and 
care is terminated. If progression is unfavourable and there is certainty that the 
patient is doing his best, a capsulotomy can be proposed. When progression is 
unfavourable and there is doubt concerning the patientˊs work or willingness, a 
clinical and radiological work-up must be done to look for a hidden problem (a 
usual patient profile, a physiotherapist “limiting” recovery but also an un-
detected organic disorder, etc.). 
 
 
2.5.2. Conservative treatment methods 
After the diagnosis, the FSS patients started with intensive conservative treat-
ment (CT), which consists of many different strategies. Conservative treatment 
methods are: different drugs (oral or injection in the shoulder joint) used for 
shoulder pain and inflammation relief; patient education, physiotherapy, diffe-
rent manipulation techniques, massage, and electrotherapy for shoulder pain 
relief and shoulder function improvement (Kelley et al., 2009). 
Levine et al. (2007) followed the treatment and recovery of 105 FSS patients. 
89.5% of the patients resolved symptoms with nonoperative treatment, in-
cluding 17 of 19 diabetic shoulders. All patients received nonsteroidal anti-
inflammatory medication, 52.4% received a standardized physiotherapy pro-
gram without cortisone injection, and 37.1% received therapy with at least 1 
corticosteroid injection. The duration of treatment in successfully nonopera-
tively treated patients averaged 4 months. Patients who needed surgery were 
treated with an average of 12 months of nonoperative treatment.  
 
Drugs 
There are several studies assessing the efficacy of different drugs (Bulgen et al., 
1984; Ryans et al., 2005; Bal et al., 2008; Lorbach et al., 2010; Blanchard et al., 
2010; Griesser et al., 2011) in the treatment of patients with FSS. Binder et al. 
(1986) followed patients with FSS for eight months: one group used oral 
prednisolone and home pendular exercises, while the other group performed 
home pendular exercises. The improvement in the treated group occurred more 
rapidly, however at the end of the study there was no difference between groups 
and the patients experienced significant restriction during shoulder ROM for the 
involved extremity as compared with normal controls. Blokcey and Wright 
(1954), and Tashijan (2012) found that the use of cortisone in the treatment of 
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patients with FSS leads to fast shoulder pain relief and improvement of shoulder 
ROM. The same recovery tendencies were found by Roh et al. (2011) in dia-
betic patients with FSS. The diclofenac epolamine (2-hydroxyethyl-pyrrolidine 
DHEP) lecithin gel is a topically effective analgesic product in the treatment of 
patients with FSS (Spacca et al., 2005). Rhind et al. (1982) concluded that 
naproxen and indomethacin were equally effective in the treatment of shoulder 
pain in patients with FSS but did little to change the loss of shoulder movement 
associated with this disorder. Buchbinder et al. (2004) have demonstrated that a 
short course of prednisolone for the treatment of patients with FSS is highly 
effective in the short term. Takase (2010) investigated the possible early symp-
tom relief with oral steroids in patients with FSS and found that the treatment 
was effective. 
 
Injection 
Corticosteroid injections of glenohumeral and subacromial space are the usual 
care for patients with FSS. Jacobs et al. (2009) recommended the use of corti-
costeroid injections, rather than MUA and physiotherapy, as a first-line treat-
ment for patients in the “freezing” phase. An intra-aricular glucocorticoid in-
jection showed better results in objective shoulder scores, during shoulder ROM, 
and in patients’ satisfaction compared with a short course of oral corticosteroids 
(Lorbach et al., 2010). Intra-articular corticosteroid injection (only one) in FSS 
stage I recovered the involved shoulder more rapidly (2 weeks to 3 months) 
than in those who were in stage II (2 week to 2 years). However, early injection 
of corticosteroid and local anaesthesia are diagnostic and therapeutic (Marx et 
al., 2007) and the combination of the corticosteroid injection and therapeutic 
exercises is effective (Bulgen et al., 1984; Carette et al., 2003; Bal et al., 2008). 
There is no difference between ultrasound (US) guided subacromial injection 
with high-dose triamcinolone acetonide (40 mg) and low-dose (20 mg), whereas 
in the initial stage a low dose is recommended (Hong et al., 2011). However, de 
Jong et al. (1998) showed that greater symptom relief was achieved with a  
40 mg dose of intra-articulary triamcinolone acetonide injection than with  
10 mg, the effect on shoulder pain and sleep disturbance was more evident than 
during shoulder ROM. Oh et al. (2011) found that steroid injection into the 
glenohumeral joint or subacromial space, followed by stretching exercises and 
non-steroidal anti-inflammatory drugs (NSAID) supplementation is an alterna-
tive modality in the treatment of patients with FSS. Roh et al. (2011) compared 
corticosteroid injections and home stretching exercises with home exercises in 
diabetic patients with FSS. They found that shoulder pain relief and shoulder 
function recovery was better and faster in the corticosteroid injection group, 
while in the long-term there were no differences between groups.  
 Fluoroscopic-guided intra-articular injection series is an effective and safe 
treatment option in the treatment of patients with FSS and leads to fast shoulder 
pain reduction and an increase in shoulder ROM (Richardson, 1975; Tveita et 
al., 2008; Lee et al., 2009; Lorbach et al., 2010). Arslan and Celicer (2001) 
investigated (a) local steroid injection of 40 mg methylprednisolone acetate  
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1 ml with 1 ml of 2% lidocaine group and (b) physiotherapy and NSAID (ace-
methazine 120 mg/day) group. Physiotherapy consisted of hot pack application 
for 20 min, US therapy at 3.5 W/cm2 for 5 min and passive glenohumeral joint 
stretching exercises to the patients’ tolerance, followed by Codman’s exercises 
and wall climbing. The study results showed that intra-articular corticosteroid 
injection was as effective as combined physiotherapy and NSAID. Jancovic and 
van Zundert (2006) demonstrated in five patients who did not respond to routine 
therapy that the selective subscapularis fossa nerve block combined with sub-
scapularis trigger point infiltration have had diagnostic and therapeutic value in 
the treatment of patients with FSS. There are several possible pathways, in-
volving anti-inflammatory and anti-fibrotic mechanisms. The analgesic effect 
can be expected to last longer than the effect of steroid injections. Chen et al. 
(2011) hypothesized that intra-articular injection of botulinum toxin can be an 
effective alternative for the treatment of FSS. They concluded that botulinum 
toxin intra-articular injection in the shoulder joint is a potential treatment for 
patients with FSS. Harris et al. (2011) showed in their systematic review that 
sodium hyaluronate injection into the glenohumeral joint significantly improves 
shoulder ROM, CS, and shoulder pain at short-term follow-up following the 
treatment of patients with FSS. On the other hand, Hsieh et al. (2012) found that 
intra-articular hyaluronic acid injections did not produce added benefits in 
patients with FSS who were already receiving physiotherapy. 
 Schydlowsky et al. (2012) found that tumour necrosis factor-alpha blockade 
with subcutaneous adalimumab compared with intraarticular steroid injections 
had no effect in patients with FSS. Ahn et al. (2008) developed a new effective 
non-surgical intervention for FSS treatment: they used three specially made 
needles in interventional microadhesiolysis.  
 
Physiotherapy 
The physiotherapist plays an important role in: composing and supervising the 
exercise program, explaining the time course of the disappearance of symptoms, 
patient education and encouraging a program of home exercises. Winters et al. 
(1997) found that in patients with shoulder girdle disorders, who were treated 
with manipulation or physiotherapy, the duration of symptoms was shorter after 
manipulation. Rizk et al. (1983) followed two different treatment programs. The 
first group was treated with therapeutic heating modalities followed by 
therapeutic exercises and gentle rhythmic stabilization manipulation, while the 
second group was treated with prolonged pulley traction and transcutaneous 
electrical nerve stimulation (TENS). The improvement was greater in the 
second group. Griggs et al. (2000) found that in stage II, patients with FSS 
should be treated with a four-direction shoulder-stretching exercise program 
that includes passive forward elevation, passive EXR, passive INR and passive 
horizontal ADD. This treatment should be continued for at least three months 
before more aggressive or invasive management is considered.  
 Gaspar and Willis (2009) achieved the best treatment results with shoulder 
Dynasplint and standardized physiotherapy. It was concluded that end range 
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mobilization treatment (three weeks) significantly improved shoulder aROM 
during ABD (Sarkari et al., 2006; Dempsey et al., 2011). In combination with a 
simple home exercise program, adding supervised physiotherapy, the improve-
ment of shoulder ROM was faster, while supervised physiotherapy alone had 
limited efficacy (Carette et al., 2003). In a single-case study, Maricar et al. 
(2009) found that exercises only and exercises with Maitland mobilization were 
beneficial in the treatment of the patient with FSS in stage III.  
 It was suggested that a multimodal nonoperative treatment program (super-
vised physiotherapy, home exercises, oral NSAID or corticosteroids, corti-
costeroid injections) is effective for most patients with FSS (Rill et al., 2011). 
Yang et al. (2011) examined the effectiveness of the end-range mobilization/ 
scapular mobilization treatment approach in FSS patients. They found that the 
end-range mobilization/scapular mobilization treatment approach was more 
effective than a standardized physiotherapy program. In a study by Boyles et al. 
(2005) the physiotherapist performed manipulation with low-amplitude proce-
dures after a regional interscalene block was performed by an anaesthesiologist. 
Patients were instructed to perform shoulder aROM exercises every two hours 
when awake at home, for the next 24 hours and apply ice packs on the shoulder 
for 20 min. The patients had received physiotherapy every day for one week, 
after that three times per week, and after three weeks, the patients continued 
with the home program. The patients showed rapid improvement during 
shoulder pROM and an improved level of disability measured by the Shoulder 
Pain and Disability Index. Johanson et al. (2007) compared the effectiveness of 
anterior versus posterior glide mobilization techniques for improving shoulder 
ROM during EXR in patients with FSS, and found that the posteriorly directed 
joint mobilization technique was more effective. 
 It has been found that high-grade mobilization techniques were more effec-
tive in improving glenohumeral joint mobility and reducing disability than low-
grade mobilization techniques (van den Hout 2005; Vermeulen et al., 2006). 
O’Kane et al. (1999) followed patients with FSS who performed a simple home 
program. They concluded that this program can lead to improvement in self-
assessed shoulder function health status, 56% of patients were able to place a 
3.6 kg weight on a shelf, and 66% were able to carry 9.1 kg at their side. 
Diercks and Stevens (2004) found that “supervised neglect” of idiopathic FSS is 
superior to passive stretching and mobilization with regard to the functional end 
results and the speed of recovery. In the van der Windt et al. (1998) study, 
patients with FSS received no more than three intraarticular injections of 40 mg 
triamcinolone acetonide (injection group), during six weeks. There were twelve 
sessions of physiotherapy with 30 min duration, during which all patients 
received passive joint mobilization and exercise treatment. Ice, hot packs, or 
electrotherapy were used to reduce shoulder pain. The study results showed that 
the corticosteroid injections group experienced quicker symptom relief as 
compared to the physiotherapy group. The study results of Ryans et al. (2005) 
were similar. However, they found that physiotherapy is effective in improving 
shoulder ROM during EXR 6 weeks after treatment. Bulgen et al. (1984) 
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followed forty-two patients with FSS for eight months. The treatment methods 
in this study were: (a) intraarticular steroids, (b) mobilization, (c) ice therapy 
and (d) no treatment group. They found that all treatments had a positive effect 
but the steroid injections may benefit shoulder pain and shoulder ROM in the 
early stages of the disease. FSS patients treated with physiotherapy (mobili-
zation), steroid injection, or with a combination had less shoulder pain and 
showed improvement at six weeks and six months (Dacre et al., 1989). Ulusoy 
et al. (2011) found that supervised physiotherapy supplemented with NSAIDs 
improved shoulder ROM values in most FSS patients. 
 In conclusion, there are many different treatment techniques used in the 
treatment of patients with FSS. However, in the opinion of the author of this 
thesis, the combination of orthopaedic massage (manipulation) and shoulder 
ROM exercises is more effective than shoulder ROM exercises alone. 
 
Therapeutic modalities 
In FSS patients, the treatment used following therapeutic modalities: different 
electrotherapy currents, cold and hot packs, US, and magnetotherapy. Leclaire 
and Bourgouin (1991) treated patients with FSS three times a week for a maxi-
mum of three months with: (a) hot pack application and passive manual 
stretching and pulley exercises, (b) hot pack application and passive manual 
stretching and pulley exercises and magnetotherapy. They concluded that 
magnetotherapy had no benefit in the treatment of patients with FSS. It was 
concluded that electroacupuncture or interferential electrotherapy in combi-
nation with shoulder exercises is effective in treating FSS patients (Leung and 
Cheing, 2008). Deep heating and stretching exercises produced greater 
improvement in shoulder pain relief, and resulted in better performance in ADL 
and shoulder ROM (Leung and Cheing, 2008). Hamer and Kirk (1976) found 
that ice and US with specific exercises shortened the painful stage and fastened 
the recovery of FSS. It has been found in studies that TENS, cold packs, 
NSAID and scapulothoracic exercises decreased shoulder pain and increased 
shoulder ROM more than glenohumeral ROM exercises alone (Celic, 2010). 
Carette et al. (2003) used different treatment programs. In the acute stage, the 
physiotherapy program consisted of TENS, mobilization techniques, shoulder 
aROM exercises, ice application. In the chronic stage, they used US, mobili-
zation techniques, active and auto-assisted shoulder ROM exercises, shoulder 
muscle isometric strengthening exercises, ice application. There were four 
different groups: (a) corticosteroid injection and 12 sessions of physiotherapy, 
(b) corticosteroid injection, (c) saline injection, followed by supervised 
physiotherapy and (d) saline injection (placebo). The fastest symptom relief and 
recovery was attained in the corticosteroid injection and physiotherapy group. 
In long-term follow-up the differences between groups disappeared. In their 
case study, Gulick et al. (2007) reported the positive effect of combined therapy 
that consisted of twelve treatments of moist heat, analgesic nerve block 
electrical stimulation; contract/relax exercises for shoulder INR and EXR, and 
Codman’s Pendulum exercises. 
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 In conclusion, the therapeutic modalities fasten shoulder pain relief and 
patients with FSS are able use their involved extremity in ADL and exercise 
performance without shoulder pain. 
 
 
2.5.3. Treatment possibilities after failed conservative treatment 
When conservative treatment in FSS patients does not had produce a positive 
effect after two or three months of treatment, the next choice is non-surgical and 
surgical intervention (Chambler and Carr, 2003; Kelley et al., 2009). The 
choices are: MUA (Jenkins et al., 2012), arthroscopic release (Kelley et al., 
2009), open capsular release (Omari and Bunker, 2001), pulsed mode radio-
frequency lesioning of the suprascapular nerve (Huang et al., 2010), sono-
guided capsular distension (Park et al., 2012), arthrographic distension 
(Quaraishi et al., 2007). The surgical release is contraindicated if the patient is 
in clinically significant depression or suffers from autonomic dystrophy. 
Arthroscopic capsular release is absolutely contraindicated in patients who 
cannot tolerate the surgical stress of fluid challenge (e.g. renal or cardiac failure) 
(Ko et al., 2011).  
 
Manipulation under general anaesthesia 
MUA is performed either under general or local brachial plexus block, which 
completely relaxes the shoulder muscles, ensuring that the force applied by the 
surgeon reaches the capsuloligamentous structures (Kelley et al., 2009; Wang et 
al., 2010; Jenkins et al., 2012).  
 In their study, Jenkins et al. (2012) described MUA as follows: “General 
anesthetic was administered with the patient supine. Once the patient was fully 
anesthetized, the patient’s scapula was fixed by gripping across the top of the 
shoulder, and the pROM of the glenohumeral joint was assessed and recorded in 
comparison with the anatomic position. INR and EXR were assessed and 
recorded by flexing the elbow to 90 deg before using the forearm as a pointer. 
Manipulation was then initiated by holding the patient’s arm between the 
shoulder and elbow and manipulating it initially into ABD, then FL, EXR, 
cross-body ADD, and finally, INR. This sequence was repeated until the 
maximum possible shoulder ROM was achieved and again recorded”. 
 MUA is a simple, safe and noninvasive procedure to improve symptoms in a 
short period of time with early physiotherapy and pool exercises (Ng et al., 
2009; Jenkins et al., 2012) even in diabetes patients (Placzek et al., 1998; 
Dodenhoff et al., 2000; Kivimäki and Pohjolainen, 2001; Othman and Taylor, 
2002; Massoud et al., 2002; Farrell et al., 2005; Wang et al., 2007; Wang et al., 
2010; Thomas et al., 2011; Jenkins et al., 2012). Early MUA (less than 9 
months from the onset of symptoms) had better recovery results (Flannery et al., 
2007). In the study with 246 FSS patients treated with MUA, 47 shoulders 
required a further MUA and three required a third manipulation (Thomas et al., 
2011). Reichmister and Friedman (1999) found that 8% of patients needed the 
second MUA to achieve good results, while Jenkins et al. (2012) reported that 
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36% diabetic and 15% nondiabetic patients with FSS needed repeated MUA 
during a 10-year study. Manipulation followed by arthroscopic release and 
rehabilitative treatment is an effective way of shortening the course of FSS 
(Andresen et al., 1998; Castellarin et al., 2004). Roubal et al. (1996) found that 
MUA following the interscalene brachial plexus blocks improved shoulder 
ROM during FL, ABD, EXR and INR. It increased function in patients, such as 
overhead activities, dressing activities, and hair combing. Several serious 
complications during the MUA procedure have been reported in studies: 
fracture of the humerus, dislocation of the glenohumeral joint, isolated paralysis 
of infraspinatus muscle and other brachial plexus traction injuries, rotator cuff 
tear, hemorrhagic effusions and hematomas (Takagishi et al., 1994; Dodenhoff 
et al., 2000). Reichmister and Frideman (1999) followed 38 patients for an 
average time of 58 months after MUA; they had no evidence of biceps tendon 
rupture or rotator cuff insufficiency, fractures, dislocations or nerve palsies in 
their study. On the other hand, it was found that MUA does not add 
effectiveness to an exercise program carried out by the patient after instruction 
(Kivimäki et al., 2007). It was demonstrated that translational manipulation 
following an interscalene block, caused rapid improvement in shoulder pROM 
and improved levels of disability as measured with the Shoulder Pain and 
Disability Index (Boyles et al., 2005).  
 
Other choices 
Arthroscopic capsular release is an effective and safe alternative to mani-
pulation in patients with FSS (Pearsall et al., 1999; Watson et al., 2000; Jerosch, 
2001; Diwan and Murrell, 2005; Baums et al., 2007; Cinar et al., 2010). It has 
been shown in studies that arthroscopic release is effective after failed 
conservative treatment, which lasted at least six weeks without progress with 
symptoms for at least three months (Ide and Takagi, 2004). Baums et al. (2007) 
demonstrated that arthroscopic release in patients with FSS combined with 
gentle manipulation provides reliable expectations for improvement in both 
clinical and general health status for most patients. De Carli et al. (2012) 
compared the use of manipulation and arthroscopic arthrolysis with gleno-
humeral steroid injections in patients with FSS and found that both of these 
treatments seemed to be effective in restoring a satisfactory shoulder ROM and 
decreasing painful symptomatology in the shoulder. Ogilvie-Harris et al. (1995) 
followed patients with FSS for 2–5 years. One year after failed conservative 
treatment, 40 patients were divided into two groups: one group of patients was 
treated with manipulation and arthroscopy and the other group with arthroscopy. 
They found that 15 of 20 patients treated with arthroscopy had excellent results 
compared with 7 of 18 patients treated with arthroscopy and manipulation. 
Selective arthroscopic capsular release was suggested to patients with FSS who 
did not respond positively to CT, and patients with diabetes may benefit from 
early intervention (Pollock et al., 1994; Ogilvie-Harris et al., 1995; Segmüller et 
al., 1995; Oglivie-Harris and Myerthall, 1997; Pearsall and Speer, 1998) and 
postoperative exercises and physiotherapy are also important for excellent 
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recovery (Sabat and Kumar, 2008). Huang et al. (2010) treated two patients 
with FSS by using real-time, high resolution US guidance to facilitate pulsed 
mode radiofrequency lesioning of the suprascapular nerve. Both patients expe-
rienced shoulder pain relief and increased shoulder flexibility for 5–6 months. 
 Open surgical release has provided good results in patients with primary FSS 
who fail to improve with either conservative treatment or MUA (Omari and 
Bunker, 2001). It has been concluded that sono-guided capsular distension is an 
advantageous technique for treating FSS from the viewpoint of radiation hazard 
mitigation, time, cost-effectiveness and convenience (Park et al., 2012). Litera-
ture recommends arthrographic distension (Sharma et al., 1993; van Royen and 
Pavlov 1996; Fareed and Gallivan, 1998; Quaraishi et al., 2007) followed by 
intraarticular steroid injection and high-intensity physiotherapy for improving 
shoulder pain and shoulder pROM in patients with FSS within the first five days, 
and retaining the improved results after one month (Laroche et al., 1998; 
Buchbinder et al., 2007). MUA is a more costly inpatient procedure, whereas 
arthrographic distension can be carried out as an outpatient procedure without 
general anaesthesia and with less attendant risks in the treatment of patients 
with FSS (Gavant et al., 1994; Fareed and Gallivan, 1998; Gam et al., 1998; 
Vad et al., 2003; Jacobs et al., 2009). On the other hand, Tveita et al. (2008) did 
not find important treatment effects when comparing three arthrographic 
distensions that included steroids with three steroid injections alone. However, 
after analyzing 11 systematic reviews of the evidence of the effectiveness of 
interventions used to manage primary FSS, Rookmoneea et al. (2010) found 
that there is a demand for standardization of diagnostic criteria, standardization 
of outcome measurement and improvement of the quality of randomized 
controlled trials in the studies of patients with FSS.  
 In conclusion, the correct diagnosis and intervention choice and active 
physiotherapy thereafter are important factors for achieving good and fast 
treatment results. 
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3. AIMS OF THE STUDY 
 
The general aim of the present study was to evaluate the recovery of shoulder 
function in patients with FSS following conservative treatment and after MUA.  
 
The specific objectives were: 
 
(1) To evaluate the changes in shoulder aROM, shoulder muscle isometric 
strength and endurance in patients with FSS before and one month after 
conservative treatment (Papers I–II). 
 
(2) To assess the changes in shoulder aROM, shoulder muscle isometric 
strength and endurance in patients with FSS before, one month and six 
months after MUA (Papers III–IV). 
 
(3) To assess the pain and the functional limitations and disability of the 
shoulder in patients with FSS before and after conservative treatment and 
MUA (Papers I–IV). 
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4. MATERIALS AND METHODS 
 
4.1. Subjects 
4.1.1. Description of the subjects  
Twenty-five patients with FSS aged 18–74 years and ten age- and gender 
matched healthy people as controls participated in this study. Table 2 demonst-
rates mean age and anthropometric characteristics of FSS patients and controls 
in the different studies. 
 
 
Table 2. Age and anthropometric characteristics of the subject groups (mean±SE). 
 
Papers N Age Height BM BMI 
           (years)  (cm) (kg)  (kg·m-2) 
Papers I–II 
Patients           10     50.2±4.6       168.7±2.8 72.7±3.8 25.6±1.0 
Controls     10 49.0±4.6 167.3±2.7 74.8±3.5 25.9±0.9 
Papers III–IV 
Patients 15 53.6±9.7 167.1±9.1 71.9±11.2 25.0±4.0 
BM = body mass; BMI = body mass index. 
 
 
In the first study (2002–2004), the participants were ten patients with FSS (7 
women and 3 men), who were treated conservatively (CT group) (Thomas et al., 
2011) and ten subjects with asymptomatic shoulders (7 women and 3 men) as 
controls (Papers I–II).  
In patients with FSS, shoulder pain and function limitation lasted 2 to 9 
months before the CT. The subjects were moderately physically active; however, 
no professional athletes were included. They had no orthopaedic or neurological 
limitations or contraindications for exercise testing or training. The final data 
analysis was conducted on all 20 subjects.  
 In the second study (2006–2008), the participants were eighteen patients 
with FSS (10 women and 8 men), who were treated with MUA in combination 
with physiotherapy (MUA group) (Papers III–IV). Subjects’ inclusion criteria 
were: unilateral FSS defined as >50% loss of pROM of the shoulder joint 
relative to the non-affected side in 1 or more of 3 movement directions (i.e. 
ABD, FL, or EXR) (Diercks, 2004), shoulder pain at rest, inability to sleep on 
the affected side. Exclusion criteria were: previous MUA of the affected 
shoulder; other conditions involving the shoulder (rheumatoid arthritis, osteo-
arthritis, damage of the glenohumeral cartilage, Hill-Sachs lesion, osteoporosis 
or malignancies in the shoulder and chest region), traumatic bone or tendon 
changes in the affected shoulder; neurologic deficits affecting shoulder function 
in ADL; shoulder pain or disorders of the cervical spine, elbow, wrist, or hand; 
and an injection with corticosteroids in the affected shoulder within 4 weeks. 
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Patients who have had serious cardiac problems or cardiac surgery were 
excluded from this study (Vermeulen et al., 2006).  
 The average duration from the onset of the disease to MUA was 8.6 months, 
ranging from 3 to 12 months. The FSS stage was II or III. The dominant 
shoulder was involved in 7 patients and the nondominant one in 11 patients. 
Three subjects did not return after the first session and were not included in data 
analysis. One subject broke the other hand one month after MUA. Two patients 
did not come back after the first session. The final data analysis was therefore 
conducted on 15 subjects. The subjects were moderately physically active; how-
ever, no professional athletes were included. They had no orthopaedic or 
neurological limitations or contraindications for exercise testing or training. All 
patients had physiotherapy about 7 times before MUA.  
 The studies were conducted in the Laboratory of Kinesiology and Bio-
mechanics at the University of Tartu. The subjects were recruited by ortho-
paedic surgeons in Tartu University Hospital, in the Department of Ortho-
paedics and Traumatology.  
 The study was carried out with the approval of the Ethics Committee of 
Human Research of the University of Tartu.  
 
 
4.1.2. Treatment 
Conservative treatment (Papers I–II). In the CT, a four-week individualized 
physiotherapy program was used for all FSS patients, which consisted of 10 
individualized exercise therapy procedures in a gymnasium and a swimming 
pool with the duration of 30 min/day. Patients performed exercises for im-
proving shoulder joint aROM and shoulder muscle strength. In the 5–10 mas-
sage procedures work was performed on the stiff and painful shoulder muscles. 
The duration of 5–10 electrical therapy procedures was 5–10 min/day (inter-
ferential current, TENS) for pain relief in the shoulder region. 
 Manipulation under general anaesthesia (Papers III-IV). The manipulation 
was done under general intravenous barbiturate anaesthesia for all patients. The 
following technique was used for manipulation: (a) gradual FL in the sagittal 
plane to maximum possible extent while the surgeon’s assistant fixed the 
scapula; (b) passive EXR was performed on 0 deg of ABD; (c) EXR in 90 deg 
of ABD; (d) INR at 90 deg of ABD and gross-body ADD were performed. Care 
was taken not to fracture the humerus during manipulation. EXR force was very 
carefully applied when the patient’s elbow was fixed and the wrist moved at the 
same time by the surgeon’s thumb and two opposing fingers. A full shoulder 
ROM was always achieved. The shoulder joint was injected with 19 ml of 1% 
Lidocaine and 1 ml of corticosteroid in a 20 ml syringe immediately after mani-
pulation. 
 All patients received immediate passive exercise in the ward soon after 
MUA. They underwent gentle active-assisted motion with a physiotherapist 
after MUA. Motion was practiced in FL, extension (EXT), ABD, ADD, INR 
and EXR. Physiotherapy continued on an outpatient basis, and included super-
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vised and therapeutic home exercise programs focused on shoulder muscle 
stretching (two times per day, five days per week). Further physiotherapy pro-
cedures included shoulder muscle isometric strengthening exercises followed by 
the use of elastic bands and power simulator as soon as post-MUA shoulder 
pain and shoulder aROM allowed. The subjects were treated by physiotherapists 
with at least 2 years of clinical experience. The subjects had ten physiotherapy 
sessions during one month, three times per week. They were advised to use the 
affected shoulder in ADL whenever possible. 
 Demographic data, including age, sex, employment status, and sports and 
leisure activities, were recorded at baseline. A history was taken concerning the 
duration of complaints (months), previous treatments (injections, physiothera-
py), and current pain medication. Concomitant diseases and the use of medi-
cation were registered.  
 
 
4.2. Study design 
The subjects were instructed and the shoulder muscle strength and isometric 
endurance testing procedures were demonstrated 24–48 hours before collecting 
the first data. This was followed by a practical session to familiarize the subjects 
with procedures. Before testing, each subject underwent a 10 min warm-up 
consisting of gymnastics and stretching exercises. Both extremities were tested, 
whereas the uninvolved extremity was tested first. The data collection was 
performed in the first study before and one month after individualized CT and 
in the second study one day before MUA, and one and six months after MUA. 
In paper I, changes in shoulder joint aROM, shoulder muscle isometric 
strength, shoulder muscle isometric endurance, and shoulder pain in patients 
with FSS and controls were assessed before and one month after individualized 
CT. 
 In paper II, changes in shoulder muscle isometric working capacity and fati-
gability of the deltoideus, infraspinatus and trapezius muscles in patients with 
FSS and controls were evaluated before and one month after individualized CT. 
 Paper III followed changes in shoulder muscle isometric strength, shoulder 
aROM, shoulder muscle isometric endurance, and self-administered SRQ in 
patients with frozen shoulder before, one and six months after MUA. 
 Paper IV described changes in shoulder aROM, shoulder muscle isometric 
strength, and shoulder pain at day and by night in patients with FSS before, one 
and six months after MUA. 
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4.3. Methods 
4.3.1. Measurement of shoulder active range of motion 
The shoulder aROM during FL, EXT, ABD and ADD was measured by gravi-
tational goniometer Bubble Inclinometer (Fabrication Enterprises Inc., USA) 
and shoulder aROM during INR and EXR was measured by gravitational gonio-
meter Myrin (Follo A/S, Norway) (Papers I–IV). The subjects were positioned 
standing for all shoulder ROM tests according to standard guidelines (Clarkson, 
2005). All measurements were rounded as is common in research practice off to 
the nearest 5 degrees (Vermeulen et al., 2000). All assessments were performed 
by the same physiotherapist.  
 
 
4.3.2. Shoulder muscle isometric strength testing 
Shoulder muscle maximal isometric strength during FL, EXT, ABD, ADD, INR 
and EXR was measured by a hand-held dynamometer (Lafayette Manual 
Muscle Test System, Lafayette Instrument Company, USA) (Papers I–IV). 
Hand-held dynamometry is considered an objective method of measuring 
muscle strength (Bohannon and. Andrews, 1987; Hayes et al., 2001; 2002). It 
has been indicated that the intraclass correlation coefficients were high ranging 
from 0.971 to 0.972 for the test-retest trials, while a hand-held dynamometer 
with a stabilization device was used for testing shoulder muscle isometric 
strength (Kolber et al., 2007). 
 During shoulder muscle strength testing, the subject was in a seated position 
on a standard chair. Shoulder muscle strength assessment during FL, EXT, 
ABD and ADD was performed with the full ended upper extremity positioned 
with the shoulder abducted to 45 deg. A hand-held dynamometer was placed 
laterally on the distal end of the humerus approximately 5 cm superior to the 
elbow joint. Shoulder muscle isometric strength assessment during INR and 
EXR was performed with the shoulder in a vertical position and the elbow 
flexed to 90 deg. The hand-held dynamometer was placed laterally (external) or 
medially (internal) on the distal part of the elbow approximately 5 cm superior 
to the wrist. The forearm was pronated during all strength tests. The position 
was carefully supervised by an experimenter and the subjects were encouraged 
to act in the required way. The subjects were asked to exert maximum voluntary 
isometric contractions pushing against the dynamometer for approximately 3 s. 
Before each contraction, the subjects were instructed to “push as hard as 
possible”. The best results from 3 attempts were recorded as isometric maximal 
voluntary strength. A rest period of 1 min was allowed between attempts. All 
shoulder muscle strength assessments were performed by the same physio-
therapist.  
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4.3.3. Shoulder muscle endurance testing and  
electromyography 
Shoulder girdle muscle isometric endurance was evaluated by weight holding 
time. During endurance testing, the subject was in a seated position on a stan-
dard chair. The full extended upper extremity was positioned with the shoulder 
flexed 45 deg and abducted 45 deg. In this position, the subject held weight in 
hand (30% of shoulder muscle maximal isometric strength assessed by a hand-
held dynamometer – Papers I–II and a weight of 5 kg for men and 3 kg for 
women, – Paper IV) as long as possible (Fig. 1).  
 Isometric working capacity of shoulder muscles was characterized by net 
impulse (NI), which was calculated by formula (Papers I–II):  
 
NI = P · t (N·s), 
 
where P is hand-held weight x 9.81, and t is endurance time.  
 During the isometric endurance test, electromyographic (EMG) activity of 
the deltoideus, infraspinatus and trapezius muscles (Paper II) was continuously 
recorded using the standard electromyograph Medicor MG 440 (Hungary). 
Paired bipolar surface electrodes (Ag-AgCl, 8 mm diameter, 20 mm inter-
electrode distance) were used. The skin under the electrode was shaved, abraded 
and cleaned with alcohol, and a conducting gel was applied to obtain a good 
signal transfer from the skin to the electrodes. The electrodes over the infra-
spinatus muscle were placed 3 to 4 cm below the spine of scapula and parallel 
to the fibres of the muscle in the middle of its belly, and over the middle deltoid 
muscle halfway between the insertion and the acromion. The electrodes over the 
upper trapezius muscle were placed one third lateral and 2 to 4 cm above the 
line from processus C7 to acromion. The ground electrode was placed at the 
radial styloid process of the non-tested arm. Correct electrode placement was 
confirmed by observing the appropriate EMG activity while performing a 
manual muscle test.  
The output signals from EMG preamplifiers were digitized one-line 
(sampling frequency 1 kHz) by an analogue-to-digital converter installed in a 
personal computer. The digitized signals were stored on a hard disk for further 
analysis, the EMG power spectrum MF was calculated by using the Fast Fourier 
Transform Algorithms, whereas a 1024 data point window (1 s) slides over the 
whole recorded signal area with a 512 point shift (50% overlap). During the 
shoulder muscle isometric endurance test, MF was determined and averaged 
over each period of 5 s, whereas the following characteristics were calculated: 
initial MF (MFi) as mean of the first 10 s and mean of the last 10 s (MFe).  
 34
Additionally, MFslope per kilogram of weight held during the endurance test 
was calculated by formula: 
 
100
60PMFi
tMFe)(MFislope MF 
  (%  min/kg), 
 
where t is endurance time, and P is weight, which was held by a subject in hand 
during the endurance test. MFslope was used for the assessment of shoulder 
muscle fatigability. 
 
 
 
 
Figure 1. Shoulder girdle muscle endurance testing. 
 
 
4.3.4. Shoulder pain assessment 
Patients reported their shoulder pain level on a self-assessment 10-point visual 
analogue scale (VAS) with endpoints of no pain (0) and the worst possible pain 
(10) (Kivimäki et al., 2007). In the CT group, shoulder pain was assessed before 
and one month after treatment at day (Papers I–II). In the MUA group, shoulder 
pain was reported at day and by night before MUA, one and six months after 
MUA (Paper III). 
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4.3.5. Shoulder Rating Questionnaire 
The functional limitation and disability of the shoulder was scored by the SRQ 
(Paper IV) before MUA and one and six months after MUA. The SRQ is a self-
administered questionnaire including global assessment shoulder pain, daily 
activities, areas of improvement and satisfaction, recreational and athletic 
activities, and work. The total score ranges from a minimum of 17 points (worst 
functional status) to a maximum of 100 points (best functional status) 
(L’Insalata 1997). 
 
 
4.4. Statistical evaluation of the data 
Data are presented as means and standard errors (±SE). One-way analysis of 
variance (ANOVA) followed by Bonferroni post hoc comparisons was used to 
evaluate differences between the involved and the uninvolved extremity. A 
paired t-test was used to evaluate differences between pre- and post-treatment 
characteristics (Papers I–IV). A level of p<0.05 was selected to indicate 
statistical significance. The main differences in measures of the present study 
(shoulder aROM and shoulder muscle isometric strength in EXR and INR) 
between the involved and the uninvolved extremity were tested for statistical 
significance (α=0.05). Statistical power analysis demonstrated that 15 partici-
pants were sufficient to detect a significant difference in shoulder aROM 
(β=0.96 and β=0.99) and shoulder muscle isometric strength (β=0.99 and 0.97) 
in EXR and INR between the involved and the uninvolved extremity before 
MUA (Paper III).  
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5. RESULTS 
 
5.1. Active range of motion in patients with frozen 
shoulder syndrome before and after conservative 
treatment and manipulation under general anaesthesia 
Conservative treatment 
Before CT, patients with FSS demonstrated a reduction (p<0.05) in shoulder 
aROM during FL, EXT, ABD and ADD for the involved extremity compared 
with the uninvolved extremity and controls (Table 3). FSS patients also showed 
a reduction (p<0.05) in shoulder aROM during INR, EXR for the involved 
extremity compared with controls before CT. There were no significant diffe-
rences in shoulder aROM during INR and EXR for the involved and the unin-
volved extremities in FSS patients before CT. After the 4-week individualized 
CT, the shoulder aROM during FL, EXT, ABD and ADD in FSS patients for 
the involved extremity increased (p<0.05) as compared with the pre-treatment 
level. However, in FSS patients, shoulder aROM during FL, EXT and ABD for 
the involved extremity remained significantly lower (p<0.05) compared with 
the uninvolved extremity and controls after CT. There were no significant diffe-
rences in shoulder aROM during ADD in FSS patients for the involved extre-
mity compared with the uninvolved extremity and controls after the 4-week CT. 
The shoulder aROM during INR and EXR in FSS patients for the involved 
extremity did not change significantly with CT.  
 
 
Table 3. Mean (±SE) values of active range of motion (aROM=deg) in frozen shoulder 
syndrome (FSS) patients (n=10) before and after conservative treatment (CT) com-
paring the involved extremity (IN) with the uninvolved extremity (UN) and control 
subjects (n=10). 
 
                                 Before     After 
Direction            IN                    UN                   IN                    UN           CONTROLS 
FL  116.5±8.7a,b 173.8±1.9 155.0±6.2a,b,c 174.5±1.5 175.5±1.8 
EXT 37.5±2.7a,b 65.5±6.6 50.5±2.5a,b,c 68.5±4.7 67.5±3.4 
ABD 73.5±11.1a,b 160.0±6.1 141.8±8.9abc 165.0±4.2 169.5±2.4 
ADD 32.9±2.8ab 48.4±3.3 46.0±2.7c 44.0±3.0 54.0±2.7 
INR 59.7±5.0b 70.5±3.9 59.5±4.8b 62.8±4.3 78.2±5.6 
EXR 50.5±5.7b 60.9±6.5 52.4±5.9b 59.5±7.5 81.7±5.2 
asignificant difference (p<0.05) compared with the uninvolved extremity,  
bsignificant difference (p<0.05) compared with controls, csignificant difference (p<0.05) 
compared with the pre-treatment level. FL–flexion, EXT–extension, ABD–abduction, 
ADD–adduction, INR–internal rotation, EXR–external rotation. 
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Manipulation under general anaesthesia  
Before MUA, patients with FSS demonstrated a reduction (p<0.05) in shoulder 
aROM during FL, ABD, EXT, ADD, INR and EXR for the involved extremity 
as compared with the uninvolved extremity (Table 4). One and six months after 
MUA, the shoulder aROM in all measured directions increased (p<0.05) in 
patients with FSS for the involved extremity as compared with the pre-MUA 
level. Six months after MUA and physiotherapy, the shoulder aROM during FL 
and EXR of the involved extremity in patients remained significantly lower 
(p<0.05) as compared with the uninvolved extremity, whereas shoulder aROM 
during INR, ABD, EXT and ADD did not differ significantly as compared with 
the uninvolved extremity. 
 
 
Table 4. Mean (±SE) values of active range of motion (aROM=deg) in frozen shoulder 
syndrome (FSS) patients (n=15) before, one and six months after manipulation under 
general anaesthesia (MUA) comparing the involved extremity (IN) with the uninvolved 
extremity (UN). 
 
                          Before                           1 month                          6 months  
Direction    IN    UN      IN              UN        IN              UN 
FL 95.5±4.8a 166.2±3.6 149.8±5.7ac 167.2±2.2 162.5±4.2abc 171.5±1.6 
EXT 33.0±2.8a 57.1±2.4 47.6±2.3ac 59.2±1.7 56.2±3.0bc 60.1±2.5 
ABD 53.0±4.9a 168.0±3.8 135.5±9.2ac 168.4±3.6 160.0±6.7bc 173.1±2.1 
ADD 32.6±1.9a 46.5±1.6 44.8±1.2ac 48.4±1.6 49.8±1.9bc 50.7±1.7 
INR 41.3±4.1a 68.2±3.4 63.4±1.5ac 70.5±2.6 73.9±2.6bc 74.6±1.3 
EXR 33.8±4.4a 62.6±3.7 49.9±3.9ac 68.4±2.5 63.3±3.4bc 74.9±3.2 
asignificant difference (p<0.05) compared with the uninvolved extremity, 
bsignificant difference (p<0.05) compared with data after one month of treatment, 
csignificant difference (p<0.05) compared with the pre-treatment level. FL–flexion, 
EXT–extension, ABD–abduction, ADD–adduction, INR–internal rotation, EXR–
external rotation. 
 
 
5.2. Shoulder muscle isometric strength in patients with 
frozen shoulder syndrome before and after conservative 
treatment and manipulation under general anaesthesia 
Conservative treatment 
Before the CT, patients with FSS showed a reduction (p<0.05) in shoulder 
muscle isometric strength during FL, ABD, ADD, INR and EXR for the 
involved extremity compared with the uninvolved extremity (Table 5) and a 
reduction (p<0.05) in shoulder muscle isometric strength during FL, ABD, 
ADD, EXR and INR compared with controls. After the 4-week CT, shoulder 
muscle isometric strength during FL and INR in FSS patients for the involved 
extremity increased (p<0.05) as compared with pre-therapy level. In patients 
with FSS, shoulder muscle isometric strength during EXR for the involved 
extremity was significantly lower (p<0.05) compared to controls after CT.  
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Table 5. Mean (±SE) values of shoulder muscle maximal isometric strength (kg) in 
frozen shoulder syndrome (FSS) patients (n=10) before and after conservative treatment 
(CT) comparing the involved extremity (IN) with the uninvolved extremity (UN) and 
control subjects (n=10). 
 
Joint                    Before                                       After 
position IN UN IN UN CONTROLS 
FL      10.8±1.7ab     17.8±1.2     15.7±1.9c 16.2±1.3   20.2±1.9 
ABD 10.3±2.0b  15.7±3.1    14.1±2.0c 16.7±1.2 17.4±1.5 
ADD         15.0±2.4b 20.3±3.0 18.1±2.0c  19.3±1.9  23.3±1.3 
INR   7.5±5.0b 11.4±2.1  8.9±1.0abc  14.5±1.2 14.5±1.5 
EXR          10.1±2.2ab 14.9±2.6 12.5±1.9abc 14.2±1.2  16.2±1.3 
a   significant difference (p<0.05) compared with the uninvolved extremity,  
b   significant difference (p<0.05) compared with controls, csignificant difference 
(p<0.05) compared with the pre-treatment level. FL–flexion, ABD–abduction, ADD–
adduction, INR–internal rotation, EXR–external rotation. 
 
 
Manipulation under general anaesthesia 
A significant baseline reduction (p<0.05) was noted in shoulder muscle iso-
metric strength for the involved extremity during FL, EXT, ABD, ADD, EXR 
and INR as compared with the uninvolved extremity before MUA (Table 6). 
Shoulder muscle isometric strength for the involved extremity in all mentioned 
joint positions increased (p<0.05) at the one-month follow-up compared with 
the baseline level, whereas the increase was significant (p<0.05) during FL and 
EXT at the six-month follow-up. After the one- and six-month follow-ups, 
shoulder muscle isometric strength for the involved extremity did not differ 
significantly compared with the uninvolved extremity. 
 
 
Table 6. Mean (±SE) values of shoulder muscle maximal isometric strength (kg) in 
frozen shoulder syndrome (FSS) patients (n=15) before and after manipulation under 
general anaesthesia (MUA) comparing the involved extremity (IN) with uninvolved 
extremity (UN). 
 
                               Before                           1 month                           6 months  
Direction              IN                 UN               IN               UN               IN               UN 
FL  10.2±1.4a 15.2±1.2 14.5±1.1c 17.9±1.1 16.3±1.3c 17.9±0.9 
EXT 10.8±0.9a 16.4±1.6 14.4±1.1c 17.7±1.2 17.2±0.9c 18.3±0.9 
ABD 8.9±1.0a 15.4±0.9 16.0±1.4c 16.3±1.1 13.6±1.0 16.2±0.8 
ADD 13.1±0.9a 17.8±1.0 18.9±1.9c 20.1±2.0 18.4±0.9bc 18.9±0.7 
INR 6.4±0.6a 11.2±1.0 10.8±1.2c 13.0±0.9 12.4±0.8c 13.3±0.9 
EXR 5.3±0.6a 10.2±0.6 7.9±0.7c 9.6±0.7 9.7±1.3c 10.6±0.7 
asignificant difference (p<0.05) compared with the uninvolved extremity,  
csignificant difference (p<0.05) compared with data after the one-month treatment, 
csignificant difference (p<0.05) compared with the pre-treatment level. FL – flexion, 
EXT – extension, ABD – abduction, ADD – adduction, INR – internal rotation, EXR – 
external rotation. 
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5.3. Shoulder muscle isometric endurance test time  
in patients with frozen shoulder syndrome before and 
after conservative treatment and manipulation  
under general anaesthesia 
Conservative treatment 
Isometric endurance test time did not differ significantly in patients with FSS 
for the involved extremity before and after CT compared with the uninvolved 
extremity and control subjects (Fig. 2). No significant changes were observed in 
endurance time in patients with FSS for the involved and the uninvolved extre-
mity after CT as compared with the pre-treatment level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Mean (±SE) isometric endurance time in patients (n=10) with frozen shoulder 
syndrome (FSS) before and after conservative treatment (CT) and in control subjects 
(n=10).  
 
 
Manipulation under general anaesthesia  
Shoulder muscle isometric endurance time was significantly shorter (p<0.001) 
at baseline for the involved extremity compared with the uninvolved extremity 
before MUA (Fig. 3). Shoulder muscle isometric endurance time was pro-
longated (p<0.01) at one- and six-month follow-ups for the involved extremity 
compared with the baseline level. After the six-month follow-up, shoulder 
muscle isometric endurance time for the involved extremity was and remained 
significantly shorter (p<0.05) compared with the uninvolved extremity. 
Uninvolved arm 
Involved arm 
Patients with FSS                                 Controls 
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Figure 3. Mean (±SE) shoulder muscle isometric endurance time in patients (n=15) 
with frozen shoulder syndrome (FSS) before and after manipulation under general 
anaesthesia (MUA) *p<0.05, **p<0.01, ***p<0.001. 
 
 
5.4. Shoulder muscle isometric working capacity in 
patients with frozen shoulder syndrome before and  
after conservative treatment  
Conservative treatment 
Before the CT, patients with FSS showed lower (p<0.05) shoulder muscle 
isometric working capacity (NI) during the shoulder muscle isometric endu-
rance test for the involved extremity as compared with controls (Fig. 4). There 
was a significant increase in NI during the shoulder muscle isometric endurance 
test in patients with FSS for the involved extremity after the 4-week CT as 
compared with the pre-treatment level. No significant differences in NI during 
the shoulder muscle isometric endurance test in patients with FSS for the in-
volved extremity were observed as compared to controls and with the unin-
volved extremity after CT. 
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Figure 4. Mean (±SE) net impulse during shoulder muscle isometric endurance test in 
patients (n=10) with frozen shoulder syndrome (FSS) before and after conservative 
treatment (CT) and in control subjects (n=10), ***p<0.001. 
 
 
5.5. Electromyogram power spectrum median frequency 
in patients with frozen shoulder syndrome before and 
after conservative treatment 
Before the CT, EMG power spectrum median frequency (MF) slope of the 
deltoideus muscle during the isometric endurance test was lower (p<0.05) in 
patients with FSS for the involved and the uninvolved extremity compared with 
control subjects (Fig. 5A). After CT, MF slope of the deltoideus muscle in FSS 
patients for the involved extremity increased (p<0.01) compared with the pre-
treatment level, whereas it did not differ significantly compared with the control 
subjects. MFslope of the deltoideus muscle in patients with FSS for the 
uninvolved extremity was lower (p<0.05) compared to control subjects after CT. 
 Before the CT, patients with FSS showed higher (p<0.05) MFslope of the 
infraspinatus muscle for the involved extremity during the isometric endurance 
test compared with the uninvolved extremity and control subjects (Fig. 5B). In 
patients with FSS, MFslope of the infraspinatus muscle for the involved 
extremity did not change significantly after the CT compared with the pre-treat-
ment level, whereas it was lower (p<0.05) than in control subjects. MFslope of 
the infraspinatus muscle in patients with FSS for the uninvolved extremity 
increased (p<0.01) compared with the pre-treatment level.  
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Figure 5. Mean (±SE) EMG power spectrum median frequency (MF) slope per 
kilogram weight, held in hand during the isometric endurance test determined from the 
deltoideus (A), infraspinatus (B), and trapezius (C) muscles in patients (n=10) with 
frozen shoulder syndrome (FSS) before and after conservative treatment (CT) and 
controls (n=10), *p<0.05, **p<0.01.  
Patients with FSS                                     Controls 
Patients with FSS                                       Controls 
Patients with FSS                                      Controls 
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Before and after the CT, MFslope of the trapezius muscle during the isometric 
endurance test in patients with FSS for the involved extremity did not differ 
significantly compared with the uninvolved extremity and control subjects (Fig. 
5C). No significant changes were found in MFslope of the trapezius muscle in 
patients with FSS for the involved extremity after the CT as compared with the 
pre-treatment level. After the CT, MFslope of the trapezius muscle in patients 
with FSS for the uninvolved extremity decreased (p<0.05) as compared with the 
pre-treatment level, whereas it did not differ significantly compared with the 
control subjects. 
 
 
5.6. Shoulder pain in patients with frozen shoulder 
syndrome before and after conservative treatment and 
manipulation under general anaesthesia 
In FSS patients, shoulder pain decreased (p<0.05) after CT as compared with 
the pre-treatment level (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Mean (±SE) shoulder pain in patients (n=10) with frozen shoulder syndrome 
(FSS) measured by the visual analogue scale (VAS) before and after conservative 
treatment (CT), ***p<0.001. 
 
 
 
 
 
 
***
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In patients with FSS, a significant decrease (p<0.05) of pain by day and at night 
was noted one and six months after MUA and physiotherapy as compared with 
the before MUA level (Fig. 7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Mean (±SE) shoulder pain in patients (n=15) with frozen shoulder 
syndrome (FSS) measured by the visual analogue scale (VAS) before, one and 
six months after manipulation under general anaesthesia (MUA), ***p<0.001 
 
 
 
5.7. Shoulder Rating Questionnaire in patients with frozen 
shoulder syndrome before and after manipulation under 
general anaesthesia 
SRQ scores improved significantly from baseline (49.7±8.7 points) to the one-
month follow-up (57.8±7.6 points, p<0.001). Significant improvements were 
also recorded from baseline to the six-month follow-up (80.1±4.8 points, 
p<0.001) (Fig. 8).  
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Figure 8. Mean (±SE) shoulder rating questionnaire score in patients (n=15) 
with frozen shoulder syndrome (FSS) before, one and six months after mani-
pulation under general anaesthesia (MUA), ***p<0.001. 
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6. DISCUSSION 
 
6.1. Active range of motion and shoulder pain 
Conservative treatment 
A marked shoulder aROM deficit was observed in patients with FSS before the 
CT, and MUA. The shoulder aROM during FL, EXT, ABD, ADD, INR and 
EXR in patients with FSS for the involved extremity was 25–59% lower, as 
compared with controls. Several previous studies demonstrated a reduced 
shoulder aROM in different directions in patients with FSS (Griggs et al., 2000; 
Vermeulen et al., 2000). The pathogenesis of primary FSS is unknown. Loss of 
dependent fold decreased capsular volume and capsular contractions have been 
demonstrated in patients with FSS (Neviaser, 1987). Additionally, contracture 
of the coracohumeral ligament, and capsular, and intraarticular subscapularis 
tendon thickening have been reported (Bunker and Anthony, 1995). Thus, the 
occurrence of the above-mentioned destructive changes might be the cause of 
shoulder aROM deficit in patients with FSS observed in this study.  
 In our study, patients with FSS showed substantial improvement in shoulder 
aROM during FL, EXT, ABD and ADD for the involved extremity after the 4-
week CT coupled with non-significant changes in shoulder aROM during INR 
and EXR. The important factor for the rehabilitation of patients with FSS is 
decreasing shoulder pain using multiple therapeutic manoeuvres (massage, 
electrical stimulation, therapeutic exercises and analgesic) (Kordella, 2002).  
 In the present study, pre-treatment shoulder pain measured by VAS in pa-
tients with FSS was 5.8 points. Shoulder pain in patients with FSS decreased 
significantly after CT as compared with the pre-treatment level. Thus, the im-
provement of shoulder aROM in patients after treatment might partly be caused 
by reduced shoulder pain. Kibler et al. (1998) showed that after the rehabi-
litation program, shoulder muscles became more elastic permitting major move-
ments in the shoulder girdle. However, the present study indicated that after CT, 
shoulder aROM during FL, EXT and ABD in patients with FSS in the involved 
extremity remained significantly lower compared with the uninvolved extremity 
and controls. Shaffer et al. (1992) showed that the post-rehabilitation deficit of 
shoulder aROM in patients with FSS was fairly long-standing. In a non-
operative treatment study, Lorbach et al. (2010) found that in patients with FSS 
the recovery of shoulder pROM during FL, ABD, INR and EXR continued for 
12 months after treatment. Binder et al. (1984) found that 48 months after 
rehabilitation, shoulder aROM in patients with FSS decreased significantly, 
compared with controls.  
 Shoulder pain reduction is important because this makes it possible to use 
the affected hand in performing therapeutic exercises and ADL. It has been sug-
gested that shoulder pain reduction is most likely attributed to the inhibition of 
mechanoreceptors and free nerve endings that are distributed in the subacromial 
bursa and the rotator cuff (Vangsness et al., 1995). 
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Manipulation under general anaesthesia  
Shoulder aROM during FL, EXT, ABD, ADD, INR and EXR was lower in pa-
tients with FSS by 30–68% as compared with the uninvolved extremity before 
MUA. The mean differences in shoulder aROM for the involved compared to 
the uninvolved extremity one and six months after MUA were 5–20%. However, 
FL and EXR remained significantly lower six months after MUA as compared 
with the uninvolved extremity. After MUA, the patients performed supervised 
physiotherapy sessions three times per week in outpatient facilities and additio-
nally performed a home exercise program. One month after MUA, the improve-
ment of shoulder aROM in patients was good, this improvement continued for 
six months after the MUA survey. Most patients in our study commented that 
the shoulder pain was bad on the first days after MUA, but they were able to 
perform normal daily tasks, including personal hygiene. 
 DePalma (1952) identified that FSS developed only when muscular inacti-
vity occurred in the shoulder joints of individuals past 40 years of age or in that 
period of life when degenerative alteration in the musculotendinous cuff, syno-
vialis, and biceps tendons were demonstrable both macroscopically and micro-
scopically. 
 Mengiadi et al. (2004) found that thickening of the coracohumeral ligament 
and the joint capsule in the rotator cuff interval, as well the subcoracoid triangle 
sign are characteristic MR arthrographic findings in FSS. Contracture of the 
rotator cuff interval is prevalent in patients with FSS (Ide and Takagi, 2004). 
Baums et al. (2007) and Wang et al. (2010) demonstrated similar shoulder pain 
and shoulder ROM recovery after arthroscopic release and MUA in patients 
with FSS during FL, INR and EXR. The limitation of shoulder aROM during 
INR and EXR is specific for patients with FSS (Farrell et al., 2005; Kivimäki et 
al., 2007). Kivimäki et al. (2007) found that shoulder aROM during EXR was 
38 deg 6 weeks, 48 deg 3 months, 59 deg 6 months, and 65 deg 12 months after 
MUA. Farrell et al. (2005) follow-up 15 years (range 8.1 to 20.6 years) for the 
shoulder aROM during EXR improved from 23 deg to 67 deg. Bunker (1995) 
found that patients with FSS regained movement and stretching within 8 week 
after manipulation. Ng et al. (2009) followed patients with FSS six weeks after 
MUA and early physiotherapy. They found that shoulder ROM during FL 
improved from 104.2 to 157.6 deg, ABD from 70.5 to 150.0 deg and EXR from 
13.9 to 45.6 deg, respectively. Rill et al. (2011) followed patients with FSS after 
MUA for a minimum of 24 months. They concluded that the fastest shoulder 
pROM recovery happened during the first 8 weeks, but recovery continued until 
the final follow-up. Six weeks after MUA patients usually continue with exer-
cises at home but with no supervision they stop doing the exercises. Andresen 
(1998) suggested that at the 12-month follow-up, 79% of patients with FSS are 
relieved from their shoulder pain and 75% regain a near to normal shoulder 
ROM after MUA. Wiley (1991) had satisfactory results in 62% of 37 cases at a 
follow-up of 6 months. Bal (2008) concluded that therapeutic exercises are 
critically important in patients with FSS. They suggested that it is important to 
educate the patients regarding the improvement in shoulder ROM.  
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 Stretching should be the focus of the treatment, whereas it can be taken 
beyond the limits of the available shoulder ROM. It is possible that a rehabi-
litation period of more than 4 weeks might be necessary to determine the 
relevant improvement in shoulder aROM in patients with FSS.  
 In our study, before MUA the mean shoulder pain by VAS was 6.1 points by 
day and 6.8 points at night. One and six months after MUA, shoulder pain 
significantly decreased by day and at night as compared to the pre-MUA level 
by 0.8 and 1.6 points one month after MUA and 0.6 and 1.1 points six months 
after MUA, respectively. Patients said that before MUA shoulder pain disturbed 
their everyday life, especially activities requiring overhead movement with the 
involved hand, and sleeping at night. 
 DePalma (1952) identified that at all times during the course of the disease, 
shoulder pain is the most significant clinical manifestation. A few days after 
MUA, patients use analgesics. One week after MUA, shoulder pain begins to 
decrease. Diwan et al. (2005) have shown that preoperative shoulder pain by 
VAS score range decreased from severe to very severe to mild-to-moderate one 
week postoperatively. This shoulder pain reduction was maintained at 12 weeks, 
and continued to reduce to mild at 6 months, and remained on this level at  
2 years. Kivimäki et al. (2007) investigated patients with FSS who were divided 
into a MUA group, and a home exercise group. Shoulder pain before therapy 
was 6.6 points in the manipulation group and 6.4 points in the exercise group, 
respectively. Outcomes were measured during follow-up examinations at 6 
weeks and 3, 6, and 12 months after manipulation. Shoulder pain in the mani-
pulation group was 4.9, 3.9, 2.0, and 1.5 points, respectively. Roubal et al. 
(2008) found that traditional manipulation after failed arthroscopic capsular 
release for recalcitrant FSS showed the shoulder pain changing as follows: at 
the initial evaluation 7, one day after post-arthroscopic release 6, after post-
translational manipulation 2, and at the two-year follow-up 1 points. 
 
 
6.2. Shoulder muscle isometric strength 
Conservative treatment 
The present study demonstrated a significant deficit in shoulder muscle iso-
metric strength in patients with FSS before CT, and MUA, whereas shoulder 
muscle isometric strength was measured by a hand-held dynamometer.  
CT group results indicated that before treatment, shoulder muscle isometric 
strength for the involved extremity was 38–48% lower in the measured direc-
tions. FSS is accompanied by shoulder pain and the patients tried to use the 
hand sparingly (Kibler, 1998; Andersen et al., 1998). It has been shown that 
ADL was markedly decreased in patients with FSS as compared with healthy 
subjects (Vermeulen et al., 2002). The decreased physical activity and shoulder 
immobilization are important factors of shoulder muscle atrophy, decreased 
strength and endurance. Kitahara et al. (2003) showed that three-week hand 
immobilization decreased hand muscle strength by 18–45%.  
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 The present study indicated a significant improvement in shoulder muscle 
isometric strength in patients with FSS in all measured directions after the 4-
week CT. The observed increase in shoulder muscle isometric strength during 
FL, ABD, ADD, INR and EXR in FSS patients for the involved extremity was 
15–31%. Thus, shoulder muscle isometric strength improvement in patients 
with FSS after CT was more pronounced for shoulder FL, ABD and ADD than 
INR and EXR. The improvement in maximal voluntary force generation capa-
city in patients with FSS may be partly caused by significantly reduced shoulder 
pain after treatment. The link that explains how voluntary muscle force 
production is impaired by pain is more difficult to explore.  
 
Manipulation under general anaesthesia  
Before MUA, patients with FSS showed a significant reduction in shoulder 
muscle isometric strength for the involved extremity as compared with the 
uninvolved extremity. Our results indicated that before MUA in patients with 
FSS, shoulder muscle isometric strength for the involved extremity was 26–
48% lower in the measured directions as compared with the uninvolved extre-
mity. One month after MUA, shoulder muscle isometric strength for the in-
volved extremity in patients with FSS increased by 27–49% in the measured 
directions, as compared with the pre-MUA level. Six months after MUA, 
shoulder muscle isometric strength in patients for the involved extremity im-
proved, while this was a non-significant difference as compared with the unin-
volved extremity.  
 Physical activity level, which varies depending on the individual’s job or 
how much they exercise, and mental factors, such as motivation or pain-related 
depression, affect the measurement of maximal strength (Kramer et al., 2005). 
A markedly reduced isometric voluntary force generation capacity of shoulder 
muscles in patients with FSS before MUA can be related to several factors: 
muscle spasm, capsular contracture and immobilization (Lin et al., 2009). It has 
been indicated that muscle strength, and both the fast-twitch and slow-twitch 
muscle fibre area significantly decreased after 5–6 weeks of immobilization 
(MacDougall et al., 1980). Decreased shoulder pain and increased shoulder 
ROM, as well as exercise therapy were important factors in improving shoulder 
muscle isometric strength in patients with FSS during the early rehabilitation 
period after MUA.  
 Andrews et al. (1996) composed the normative values for isometric muscle 
strength with a hand-held dynamometer for asymptomatic adults. In the 50–59-
year-old group, the mean values of shoulder muscle isometric strength during 
INR and EXR in the dominant hand were 10.3 and 10.4 kg in women, and 15.9, 
and 19.7 kg in men, respectively.  
 In our study of patients with FSS, the isometric strength of shoulder muscles 
for the uninvolved extremity was similar while, isometric strength for the 
involved extremity 6 months after MUA was lower.  
 Bohannon (1986) measured shoulder muscle isometric strength in patients 
with neurological diagnoses, and found that the mean strength during ADD, 
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INR and EXR was 8.6, 8.2, and 9.7 kg, respectively. This indicates that 
shoulder muscle isometric strength decreased in different diseases. It is im-
portant to begin with strength exercises as soon as possible with FSS patients 
after MUA. Cadogan et al. (2011) demonstrated that the resisted muscle test for 
peak isometric muscle strength during resisted ABD (the affected side) with a 
manual muscle tester had high levels of reliability. Hirschmann et al. (2010) 
found a high retest reliability for the strength measurements in all evaluated 
positions (shoulder ABD in 30, 60, 90 deg). We believe that shoulder muscle 
isometric strength assessment in patients with FSS is important because in 
successful ADL activities we needed near normal shoulder ROM and muscle 
strength. Wong and Tan (2010) noted that in examining patients with FSS, mild 
disuse atrophy of the deltoid and supraspinatus have usually been observed in 
long-standing cases. DePalma (1963) noted that all shoulder motions are 
guarded, and painful atrophy of the deltoid and spinatus muscle can be detected.  
 Before MUA, the patients’ movements are limited and painful and muscles 
are inactive. This condition is ideal for the development of muscle atrophy. 
Immediately after MUA, patients should begin with physiotherapy. Othman and 
Taylor (2002) noted that an aggressive postoperative physiotherapy regime is 
essential immediately after MUA in patients with FSS. It has been suggested 
that the recruitment of motor units is dependent on produced muscle force, 
which is smaller in the pain condition compared with the non-pain condition. 
The effect of muscle pain on the motor system can be seen as an adaptation to 
pain (Madeleine, 2010). The pain-adaptation model and the neural mechanisms 
subserving these changes in motor function during muscle pain can be related to 
reciprocal inhibition or excitation of motoneurons. It has been demonstrated that 
experimentally induced muscle pain decreases motor unit firing rate during sub-
maximal isometric contractions in humans (Farina et al., 2004). Henneman et al. 
(1965) showed that the recruitment of motor units was dependent on the pro-
duced torque, which was smaller in the pain condition compared with the non-
pain condition. Muscle pain influences motor control via numerous reflex and 
central mechanisms (Roubal and Placzek, 2008).  
 This can explain why shoulder muscle isometric strength in patients with 
FSS before MUA, and one month after MUA was lower as compared with the 
uninvolved extremity. When shoulder pain decreased, patients with FSS were 
able to produce more strength in shoulder muscles, and could increasingly use 
the involved extremity in ADL. Roe et al. (2000) explained that in patients with 
rotator tendinosis, the increase in muscle activation could be caused by a 
combination of the training effect on the muscles, and increased motor drive. It 
has been demonstrated that the increase in shoulder muscle strength is related to 
the decrease in shoulder pain perception and the psychological improvement the 
patients experienced during the program (Koumandakis et al., 2005) and such 
improvements have been positively related to the muscle strength level before 
rehabilitation (Mannion et al., 2001). In five chronic musculoskeletal disease 
conditions, Lund et al. (1991) found that pain reduces agonist and increases 
antagonist muscle activity. Graven-Nielsen et al. (1997) concluded that muscle 
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pain reduces isometric force as well as endurance during submaximal isometric 
contractions.  
 However, if patients with FSS did not feel pain in the shoulder joint and 
muscles, they started to use the involved extremity more in ADL, which helped 
them improve shoulder muscle condition. 
 
 
6.3. Shoulder muscle isometric endurance test time 
Before treatment, the shoulder muscle isometric endurance time was signifi-
cantly shorter for the involved extremity in the MUA group patients, whereas 
there was no difference in the shoulder muscle isometric endurance time in the 
CT group patients.  
 The shoulder muscle isometric endurance time in patients with FSS for the 
involved extremity before MUA was shorter by 65% as compared with the 
uninvolved extremity. Before MUA, six patients failed to perform the shoulder 
muscle isometric endurance test; they were not able to hold the weight at the 
target level. One month after MUA, the mean shoulder muscle isometric endu-
rance time in patients for the involved extremity was shorter by 37% as com-
pared with the uninvolved extremity, whereas three patients failed to perform 
the endurance test. Six months after MUA, shoulder muscle isometric endu-
rance time in patients with FSS for the involved extremity was shorter by 33% 
as compared with the uninvolved extremity, whereas two patients failed to 
perform this test. This improvement in shoulder muscle function might pri-
marily result from the neural adaptation observed, especially during the earlier 
weeks of exercise training (Häkkinen et al., 1998).  
 Pain has been shown to be an important predictor of isometric endurance of 
shoulder muscles (Brox et al., 1996). Brox et al. (1996) showed that increased 
shoulder pain, emotional stress and muscle weakness were the limiting factors 
for shoulder muscle isometric endurance in patients with rotator tendonitis of 
the shoulder. However, it has been suggested that after local shoulder pain 
reduction, endurance time remains unchanged indicating that pain reduction is 
not sufficient to improve shoulder muscle endurance (Brox et al., 1997). The 
musculature of the shoulder joint can be divided into intrinsic (centering and 
stabilizing) and extrinsic (mobilizing) muscle groups (Irlenbusch, 1999). It is 
known that more than in other joints, shoulder movements require a control 
system for constant readjustment of the intramuscular coordination of all 
muscles involved. It has been speculated that improved intra- and intermuscular 
coordination, reduced shoulder pain, shoulder muscle atrophy and increased 
shoulder joint mobility are possible factors for improvement of shoulder muscle 
function in patients with FSS after rehabilitation. It is very important to pay 
attention not only to the strengthening of the shoulder region muscles in the 
rehabilitation program after MUA in patients with FSS, but also to the im-
proving the endurance of these muscles. It can be concluded that the recovery of 
shoulder muscle endurance in patients with FSS after MUA is more delayed 
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than the recovery of shoulder muscle isometric strength. A shoulder muscle 
endurance training program should be recommended for patients after MUA.  
 In the CT group, the recovery of shoulder muscle isometric endurance time 
did not differ significantly during one month of rehabilitation, whereas in the 
MUA group the shoulder muscle isometric endurance time recovery was lower. 
It can be seen that the shoulder muscle function was worse in the MUA group. 
It could be explained by the longer disease period. 
 
 
6.4. Changes in electromyogram power spectrum during 
shoulder muscle isometric endurance test 
We examined the EMG power spectrum MFslope over time per kilogram 
weight, which was held in hand during the shoulder muscle isometric endurance 
test, whereas MFslope recordings were obtained from the deltoideus, infra-
spinatus and trapezius muscles. The results indicated that MFslope of the 
infraspinatus and trapezius muscles was unchanged by CT for the patients’ in-
volved extremity, whereas this parameter increased by 29% for deltoideus 
muscle following CT. In patients with FSS, MFslope of the infraspinatus 
muscle for the involved extremity was significantly higher before and after the 
CT compared with the control subjects and the uninvolved extremity indicating 
higher fatigability. Thus, FSS leads to a significant increase in fatigability of the 
infraspinatus muscle. For deltoideus and trapezius muscles, MFslope in patients 
for the involved extremity did not differ significantly after CT as compared to 
the uninvolved extremity and healthy controls.  
 The EMG power spectrum MF or half-power point of the EMG measures 
was used as an indicator of local muscle fatigue (Merletti et al., 1984; De Luca, 
1993). During sustained contraction, metabolic factors may contribute to 
reducing force production and this is compensated by a gradual increase in 
motor drive leading to an increased number of active motor units (Bigland–
Ritchie et al., 1986). This increase is reflected in a progressive increase in EMG 
amplitude and in a shift of EMG power spectrum to the lower frequencies 
(spectral compression) (Merletti et al., 1984; De Luca, 1993). The initial value 
of MF was associated with the distribution of the muscle fibre type recruited 
(Mannion and Dolan, 1996), while MFslope, i.e. the rate of decline over time 
was associated with the fatigability properties of the active motor units (De 
Luca, 1993). EMG power spectrum MFslope (spectrum compression) during a 
fatiguing submaximal contraction has been attributed to the changes in the 
action potential propagation of individual muscle fibres, which are the result of 
the underlying accumulation of metabolites (i.e. H+, lactate and extracellular K+) 
(Bigland–Ritchie et al., 1981; Tesch et al., 1983) during the fatiguing 
contraction reducing intracellular pH (Brody et al., 1991), and thus, decreasing 
sarcolemma excitability.  
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6.5. Shoulder Rating Questionnaire 
The present study demonstrated that the mean SRQ score in patients with FSS 
increased from 50 points of 100 before MUA to 58 and 80 points of 100 at one 
and six months after MUA, respectively. Therefore, it has to be considered that 
the functional limitation and disability of the involved shoulder in patients with 
FSS after MUA in our study markedly decreased during the 6-month post-treat-
ment period. This means that after MUA, the patients were able to perform 
more active movements with the involved upper extremity. Similar SRQ score 
improving tendencies were reported in a study by Marx et al. (2007), where the 
SRQ score improved 6 months after intraarticular corticosteroid injections 
meanly to 90 (52–100) points. In the Vermeulen et al. (2006) study, the mean 
changes in the SRQ score after using the high-grade mobilization technique 
were 37.5 initial, 25.8 three months after treatment, 32.3 six months after treat-
ment and 38.3 twelve months after treatment, respectively.  
 In conclusion, when shoulder pain was relieved in patients with FSS, 
shoulder aROM, shoulder muscle isometric strength and shoulder muscle iso-
metric endurance time increased, fatigability decreased and the involved extre-
mity function improved. Patients are more active in everyday life, whereas 
extreme movements are limited in a number of patients for a long time. 
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CONCLUSIONS 
 
1. In patients with FSS, a markedly reduced shoulder active range of motion 
and shoulder muscle isometric strength for the involved extremity was ob-
served before conservative treatment and MUA.  
 
2. A conservative treatment program with the duration of one month improved 
shoulder active range of motion during flexion, extension, abduction and 
adduction in patients with FSS with no effect on shoulder external and 
internal rotation. The improvement of shoulder muscle isometric strength 
after this treatment was more pronounced for shoulder flexors, abductors and 
adductors than in external and internal rotators.  
 
3. In patients with FSS, isometric working capacity of shoulder flexors for the 
involved extremity during sustained submaximal contraction improved after 
one month of conservative treatment. 
 
4. The fastest improvement of shoulder active range of motion and shoulder 
muscle isometric strength in patients with FSS proceeded following the first 
month after MUA. Shoulder active range of motion during flexion and 
external rotation remained reduced six months after MUA. 
 
5. The recovery of shoulder muscle isometric endurance after MUA was more 
delayed than the recovery of isometric strength and shoulder active range of 
motion.  
 
6. In patients with FSS, shoulder pain reduced markedly following one month 
of conservative treatment and MUA, and functional limitation and disability 
of the involved shoulder progressively decreased following six months of 
MUA.  
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SUMMARY IN ESTONIAN 
 
Õlaliigese ja õlavöötme lihaste funktsionaalse seisundi  
muutused adhesiivse kapsuliidiga patsientidel konservatiivse 
ravi ja redressiooni mõjul 
Sissejuhatus 
Adhesiivne kapsuliit on haigusseisund, mida iseloomustab tugev valu õla-
liigeses eriti liigutuste sooritamisel ning õlaliigese aktiivse ja passiivse liikuvuse 
oluline vähenemine. Haiguse esinemissagedus populatsioonis on 2–5%, kus-
juures sagedamini esineb seda naistel vanuses üle 40 eluaasta. Adhesiivne 
kapsuliit võib tekkida pärast õlaliigese traumat ning kaasneda südameveresoon-
konna ja kopsuhaigustega, radikulopaatiaga, diabeediga või insuldiga, põhjus-
tades patsientidele raskusi igapäevaelu toimetustega hakkamasaamisel. See-
juures on selle haiguse etioloogia veel ebaselge. Ravi esmaseks ülesandeks on 
valu leevendamine õlaliigeses ning õlaliigese funktsiooni taastamine. Kasutusel 
on erinevaid ravimeetodeid, kuid reeglina alustatakse konservatiivse raviga, kus 
olulisel kohal on füsioteraapia ja liigesesisesed süstid. Kui konservatiivne ravi ei 
ole andnud kolme kuni kuue kuu jooksul haiguse diagnoosimisest oodatud 
tulemusi, siis kasutatakse kas mittekirurgilist ravi (näiteks redressiooni üld-
anesteesias) või kirurgilist ravi (õlaliigese artroskoopiline kapsulotoomia jne).  
 Läbitöötatud kirjanduse põhjal võib väita, et adhesiivse kapsuliidiga patsien-
tide funktsionaalse seisundi hindamiseks kasutatakse erinevaid küsimustikke, 
hinnatakse valu õlaliigeses ning kahjustatud õlaliigese liikuvust. Samas on vähe 
informatsiooni õlavöötme lihaste jõu, vastupidavuse ja väsimuse kohta. 
 
 
Uurimistöö eesmärk ja ülesanded 
Uurimistöö eesmärgiks oli välja selgitada õlaliigese ja õlavöötme lihaste funkt-
sioonaalse seisundi taastumise iseärasused adhesiivse kapsuliidiga patsientidel 
pärast konservatiivset ravi ja redressiooni üldanesteesias. 
Töös püstitati järgmised ülesanded: 
1. Määrata muutused õlaliigese aktiivses liikuvuses, õlavöötme lihaste iso-
meetrilises jõus ja vastupidavuses adhesiivse kapsuliidiga patsientidel enne 
ja pärast ühekuulist konservatiivset ravi (I–II artikkel); 
2. Määrata muutused õlavöötme lihaste isomeetrilises jõus, vastupidavuses ja 
õlaliigese aktiivses liikuvuses adhesiivse kapsuliidiga patsientidel enne, üks 
kuu ja kuus kuud pärast redressiooni üldanesteesias (III–IV artikkel); 
3. Hinnata valu õlaliigeses ja funktsionaalseid piiranguid adhesiivse kapsu-
liidiga patsientidel enne ja pärast konservatiivset ravi ja redressiooni üld-
anesteesias (I–IV artikkel). 
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Uuritavad ja kasutatud metoodika 
Uuringus osales 28 adhesiivse kapsuliidiga patsienti ning 10 õlaliigese- ja 
kaelavaevusteta inimest (kontrollrühm). Uuringud viidi läbi Tartu Ülikooli kine-
sioloogia ja biomehaanika laboris ja füsioteraapia Tartu Ülikooli Kliinikumi 
Spordimeditsiini ja Taastusravi Kliiniku ambulatoorses osakonnas. 
 Esimeses uuringus osales 10 adhesiivse kapsuliidiga patsienti (7 naist ja 3 
meest), moodustades konservatiivse ravi grupi. Teises uuringus osales 18 
adhesiivse kapsuliidiga patsienti (10 naist ja 8 meest), kellel teostati õlaliigese 
redressioon üldanesteesias. 
 Konservatiivse ravi rühma liikmed läbisid 10 individuaalse füsioteraapia 
seanssi, mis koosnes terapeutilisest harjutusest saalis ja basseinis õlaliigese 
liikuvuse ning lihasjõu taastamiseks, samuti massaažist ja elektroteraapiast 
õlavöötme piirkonna valu leevendamiseks. 
 Redressiooni üldanesteesias teostas ortopeed. Sellele järgnes patsientidel 
individuaalne füsioteraapia õlaliigese funktsiooni taastamiseks. 
 Õlaliigese aktiivne liikuvus määrati seisvas asendis õlavarre fleksioonil, 
ekstensioonil, abduktsioonil, aduktsioonil, sise- ja välisrotatsioonil (Mellin et al., 
1994, Braddom et al., 1996; Clarkson 2005). Kasutati goniomeetreid (Bubble 
Inclinometer, USA ja Myrin, Norra). Goniomeetri näit fikseeriti uuritava liigu-
tuse lõppasendis. 
 Õlavöötme lihaste tahteline isomeetriline maksimaaljõud määrati istuvas 
asendis õlavarre fleksioonil, ekstensioonil, abduktsioonil, aduktsioonil, sise- ja 
välisrotatsioonil. Kasutati manuaalset lihastestrit (Lafayette Manual Muscle Test 
System, USA). Lihastester fikseeriti lähteasendisse, kusjuures vajalik nurk õla-
liigeses määrati goniomeetriga (Arthrodial Protractor, USA). 
Õlavöötme lihaste staatilise vastupidavuse testimisel istus vaatlusalune toolil, 
hoides sirget kätt ees 45 nurga all õlaliigeses (õlavars oli viidud 45º fleksioon- 
ja abduktsioon-asendisse). Konservatiivse ravi grupi liikmetel tuli selles asendis 
hoida käes raskust, mis moodustas 30% tahtelisest isomeetrilisest maksimaal-
jõust ning redresseeritud õlaliigesega patsientidel raskust, mis oli naistel 3 kg ja 
meestel 5 kg. Vastupidavustest sooritati suutlikkuseni. Õlavöötme lihaste staa-
tilist vastupidavust hinnati raskuse hoidmise aja järgi. Raskuse hoidmise käigus 
registreeriti delta-, trapets- ja harjaaluse lihase bioelektrilist aktiivsust elektro-
müograafiga (Medicor MG 440, Ungari). 
 Valu õlaliigeses hinnati patsientidel 10-punktilise visuaal-analoog skaala 
(VAS) abil: 0 – valu ei ole, 10 – äärmuslik valu (Kivimäki et al., 2007). 
Spetsiaalse õlavaevuste küsimustikuga (“Shoulder Rating Questionnaire”) 
hinnati patsientidel igapäevaelu toimetustega hakkamasaamist.  
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Järeldused 
1. Adhesiivse kapsuliidiga patsientidel oli õlaliigese aktiivne liikuvus ja õla-
vöötme lihaste isomeetriline jõud haigel jäsemel oluliselt vähenenud enne 
konservatiivset ravi ja redressiooni üldanesteesias. 
 
2. Ühekuulise konservatiivse ravi tulemusena paranes patsientidel õlaliigese 
aktiivne liikuvus fleksioonil, ekstensioonil, abduktsioonil ja aduktsioonil, 
kuid raviefekti ei ilmnenud õlaliigese aktiivses liikuvuses sise- ja välisrotat-
sioonil. Ravi järgselt toimus õlavöötme lihaste isomeetrilise jõu suurenemine, 
mis oli enam väljendunud õlavöötme fleksorites, abduktorites ja aduktorites 
võrrelduna sise- ja välisrotaatoritega. 
 
3. Ühekuulise konservatiivse ravi tulemusena suurenes patsientidel õlavöötme 
lihaste staatiline töövõime, hinnatuna lihasvastupidavuse näitajate alusel. 
 
4. Patsientidel toimus haige jäseme õlaliigese aktiivse liikuvuse kiirem taastu-
mine esimese kuu jooksul pärast redressiooni üldanesteesias. Seejuures 
õlaliigese aktiivne liikuvus fleksioonil ja välisrotatsioonil jäi piiratuks kuus 
kuud pärast redressiooni üldanesteesias. 
 
5. Pärast redressiooni üldanesteesias oli patsientidel õlavöötme lihaste staatilise 
vastupidavuse taastumine aeglasem võrreldes nende lihaste isomeetrilise jõu 
ja õlaliigese aktiivse liikuvusega.  
 
6. Nii pärast konservatiivse ravi algust kui ka redressiooni üldanesteesias 
vähenes patsientidel märgatavalt valu õlaliigeses esimese kuu lõpuks. Kuue 
kuu jooksul pärast redressiooni üldanesteesias vähenes patsientidel progres-
seeruvalt õlaliigese funktsionaalne piiratus. 
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